| 1 | 100 MG ELX/50 MG TEZ/75 MG IVA fixed dose combination | - | - | - | - | 1件: 299 299 💬
|
| 2 | 129XE small and large human lung coil | - | - | - | - | 1件: 299 299 💬
|
| 3 | 13 valent conjugated pneumococcal vaccine | - | - | - | - | 1件: 265 265 💬
|
| 4 | 13-valent pneumococcal conjugate vaccine | - | - | - | - | 2件: 46 46, 53 💬
|
| 5 | 15-O labeled water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 46 46 💬
|
| 6 | 150 MG double-blinded secukinumab (Cosentyx, COSENTYX) | - | - | - | - | 1件: 271 271 💬
|
| 7 | 150 MG OPEN-label secukinumab (Cosentyx, COSENTYX) | - | - | - | - | 1件: 271 271 💬
|
| 8 | 20MG/0.5ML glatiramer acetate (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 9 | 24 hour copper IN urine and liver function test | - | - | - | - | 1件: 171 171 💬
|
| 10 | 26 common fabry mutation types IN taiwan | - | - | - | - | 1件: 19 19 💬
|
| 11 | 2ML peripheral venous blood WAS collected TO detect genetic genes | - | - | - | - | 1件: 97 97 💬
|
| 12 | 300 MG double-blinded secukinumab (Cosentyx, COSENTYX) | - | - | - | - | 1件: 271 271 💬
|
| 13 | 3HE human lung coil | - | - | - | - | 1件: 299 299 💬
|
| 14 | 40 MG glatiramer acetate (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 15 | 40 MG glatiramer acetato (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 16 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | 1件: 97 97 💬
|
| 17 | 5% glucose water solution (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 2 2 💬
|
| 18 | 5% lidocaine/5 MG/ML 0.02% estradiol compound cream | - | - | - | - | 1件: 226 226 💬
|
| 19 | 5-probe cocktail | - | - | - | - | 1件: 254 254 💬
|
| 20 | 50 MG ELX/25 MG TEZ/37.5 MG IVA fixed dose combination | - | - | - | - | 1件: 299 299 💬
|
| 21 | 5000 IU OF cholecalciferol (Colecalciferol) | - | - | - | - | 1件: 299 299 💬
|
| 22 | 6-minute walk distance test with supplemental oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 2件: 86 86, 88 💬
|
| 23 | 60% oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 85 85 💬
|
| 24 | 7-valent pneumococcal conjugate vaccine | - | - | - | - | 1件: 46 46 💬
|
| 25 | 90 MG hydrocortisone acetate suppository with sephure suppository applicator (Colocort, Cortef, CORTEF, CORTENEMA) | 3件: Acetate Acetate, Hydrocortisone (Cortisol), Hydrocortisone acetate (Cortisol 21-acetate) | 2件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA),
Hydrocortisone acetate
(Cortifoam, U-cort, CORTIFOAM) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 26 | 90 MG idrocortisone acetato IN supposta CON applicatore PER supposte sephure | - | - | - | - | 1件: 97 97 💬
|
| 27 | A fixed-dose combination OF 95 MG clarithromycin, 45 MG rifabutin, and 10 MG clofazimine | - | - | - | - | 1件: 96 96 💬
|
| 28 | A natural remedy FOR rheumatoid arthritis VS. common drugs | - | - | - | - | 1件: 46 46 💬
|
| 29 | AAV9-CAG-COH-sgsh | - | - | - | - | 1件: 19 19 💬
|
| 30 | Aavrh.10cuhcln2 vector 2.85x10^11 genome copies | - | - | - | - | 1件: 19 19 💬
|
| 31 | Aavrh.10cuhcln2 vector 9.0x10^11 genome copies | - | - | - | - | 1件: 19 19 💬
|
| 32 | Aavrh.10hfxn, serotype RH.10 adeno-associated virus (AAV) gene transfer vector expressing THE cdna coding FOR human FXN | - | - | - | - | 1件: 18 18 💬
|
| 33 | Abdominal compression | - | - | - | - | 2件: 6 6, 17 💬
|
| 34 | Acceptance and commitment therapy | - | - | - | - | 1件: 97 97 💬
|
| 35 | Acei / angiotensin converting enzyme inhibitor | - | - | - | - | 1件: 234 234 💬
|
| 36 | Acei/ARB and corticosteroids | - | - | - | - | 1件: 66 66 💬
|
| 37 | ACH-0144471 compresse | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 222 222 💬
|
| 38 | ACH0144471 compresse | - | - | - | - | 1件: 222 222 💬
|
| 39 | Acomplia 20 MG FILM-coated tablets | - | - | - | - | 1件: 193 193 💬
|
| 40 | Activated prothrombin complex concentrate | 1件: Anti-inhibitor coagulant complex Anti-inhibitor coagulant complex (Anti-inhibitor coagulant complex) | 1件: Human blood-coagulation factor eight inhibitor bypassing activity complex, dried
Human blood-coagulation factor eight inhibitor bypassing activity complex, dried
(Human blood-coagulation factor eight inhibitor bypassing activity complex, dried, Anti-inhibitor coagulant complex) 💬
| - | - | 1件: 288 288 💬
|
| 41 | Active comparator | - | - | - | - | 5件: 6 6, 43, 44, 46, 96 💬
|
| 42 | Active control | - | - | - | - | 1件: 13 13 💬
|
| 43 | Actonel 5MG film coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
| 44 | Actonel once A week 35 MG FILM-coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
| 45 | Actonel once A week 5MG film coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 113 113 💬
|
| 46 | Actonel/optinate 5MG FILM-coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
| 47 | Acupuncture combined with oral hydroxychloroquine sulfate tablets | - | - | - | - | 1件: 53 53 💬
|
| 48 | AD libitum water intake (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 67 67 💬
|
| 49 | AD26.COV2-S.02 | - | - | - | - | 1件: 299 299 💬
|
| 50 | AD26.COV2.S | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 51 | Adalimumab serum trough concentration | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 52 | Adalimumab trough concentration | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 53 | Adcirca 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 54 | Adempas 1 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 55 | Adempas 1.5 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 56 | Adempas 2 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 57 | Adempas 2.5 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 58 | Adempas® 0.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 59 | Adempas® 1.0 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 60 | Adempas® 1.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 61 | Adempas® 2.0 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 62 | Adempas® 2.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 63 | Adempas¿ 0.5 MG compressa rivestita CON film | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 64 | Adeno-associated viral vector serotype 8 containing THE human MD1 gene | - | - | - | - | 1件: 113 113 💬
|
| 65 | Adeno-associated viral vector serotype 9 containing THE human MINI-dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
| 66 | Adeno-associated viral vector serotype 9 containing THE human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | 1件: 19 19 💬
|
| 67 | Adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene | - | - | - | - | 1件: 127 127 💬
|
| 68 | Adeno-associated viral vector serotype RH10 containing THE human cholesterol 24-hydroxylase gene | - | - | - | - | 1件: 8 8 💬
|
| 69 | Adeno-associated virus serotype HU68 containing THE human galc gene | - | - | - | - | 1件: 19 19 💬
|
| 70 | Adeno-associated virus serotype RH74 containing THE human delandistrogene moxeparvovec dystrophin gene | 1件: Delandistrogene moxeparvovec Delandistrogene moxeparvovec | 1件: Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
| 71 | Adeno-associated virus serotype RH74 containing THE human micro- dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
| 72 | Adeno-associated virus serotype RH74 containing THE human micro-dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
| 73 | Adherence counseling | - | - | - | - | 1件: 13 13 💬
|
| 74 | Adjuvant without active component | - | - | - | - | 2件: 6 6, 17 💬
|
| 75 | Adrenal cortical hormone | - | - | - | - | 1件: 224 224 💬
|
| 76 | Adrenal cortisol synthase (CYP11b1) staining | - | - | - | - | 1件: 75 75 💬
|
| 77 | AIR - oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 299 299 💬
|
| 78 | Alemtuzumab (already received BY alemtuzumab cohort between 1991 and 1994 | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 46 46 💬
|
| 79 | Allogeneic human umbilical cord tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 80 | Allogeneic mesenchymal stromal cells derived from THE umbilical cord | - | - | - | - | 1件: 49 49 💬
|
| 81 | Allogeneic umbilical cord mesenchymal stem cell and adipose secretome implantation | - | - | - | - | 1件: 17 17 💬
|
| 82 | Allogeneic umbilical cord mesenchymal stem cell implantation | - | - | - | - | 1件: 17 17 💬
|
| 83 | Allogeneic umbilical cord mesenchymal stem cells | 1件: Allogeneic umbilical cord mesenchymal stem cells Allogeneic umbilical cord mesenchymal stem cells (Allogenic umbilical cord-derived mesenchymal stem cells) | - | - | - | 1件: 13 13 💬
|
| 84 | Ambrisentan 5 MG FILM-coated tablets | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 85 | Amiodarone (Cordarone) | 1件: Amiodarone Amiodarone | 2件: Amiodarone hydrochloride
Amiodarone hydrochloride
(Cordarone),
Amiodarone
💬
| 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12_18, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 34件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Hormone signaling, Insulin secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 127 127 💬
|
| 86 | Ammonium chloride (Conclyte-A) | 1件: Ammonium chloride Ammonium chloride | 1件: Ammonium chloride
Ammonium chloride
(Conclyte-A) 💬
| - | - | 1件: 251 251 💬
|
| 87 | Amplification BY PCR and direct sequencing ON THE entire coding sequence and intron-exons boundaries OF THE candidate gene | - | - | - | - | 1件: 265 265 💬
|
| 88 | Androgel 10 grams OF GEL containing 100 MG OF testosterone | 1件: Testosterone Testosterone | 1件: Testosterone
Testosterone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 💬
|
| 89 | Angio-optical coherence tomography | - | - | - | - | 1件: 41 41 💬
|
| 90 | Angiotensin converting enzyme test | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 49 49 💬
|
| 91 | Angiotensin-converting enzyme (ACE) inhibitor | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 224 224 💬
|
| 92 | Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 💬
|
| 93 | Anti human granulocyte-macrophage colo | - | - | - | - | 1件: 46 46 💬
|
| 94 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal | - | - | - | - | 1件: 46 46 💬
|
| 95 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody | - | - | - | - | 1件: 46 46 💬
|
| 96 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 💬
|
| 97 | Anti TNF humanized antibody FAB fragment-PEG conjugate | - | - | - | - | 1件: 96 96 💬
|
| 98 | ANTI-(complement C5A) IGG4 chimeric monoclonal antibody | - | - | - | - | 1件: 269 269 💬
|
| 99 | ANTI-TNF humanized antibody FAB fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬
|
| 100 | ANTI-TNF humanized antibody FAB' fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬
|
| 101 | ANTI-tnfa continued perioperatively | - | - | - | - | 1件: 46 46 💬
|
| 102 | Antibiotic cocktail | - | - | - | - | 1件: 97 97 💬
|
| 103 | Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal | - | - | - | - | 1件: 46 46 💬
|
| 104 | Antimicrobial therapy: CO-trimoxazole or doxycycline | - | - | - | - | 1件: 85 85 💬
|
| 105 | Antioxidant cocktail | - | - | - | - | 1件: 299 299 💬
|
| 106 | Arcoxia 90 MG comprimidos recubiertos CON PELícula | - | - | - | - | 1件: 271 271 💬
|
| 107 | Arzerra - 100 MG - concentrato PER soluzione PER infusione - USO endovenoso - flacone(vetro) - 5 ML(20MG/ML) 3 flaconi | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 108 | Arzerra - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 50 ML (20 MG/ML) 1 flaconcino + 2 KIT DI prolunga | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 109 | Assessment OF cognition | - | - | - | - | 1件: 6 6 💬
|
| 110 | Assessment OF impact OF MS ON cognition | - | - | - | - | 1件: 13 13 💬
|
| 111 | Assessment OF medication compliance | - | - | - | - | 1件: 98 98 💬
|
| 112 | Assessment OF therapy complications | - | - | - | - | 1件: 60 60 💬
|
| 113 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - bister (ALU/ALU) perforato monodose - 10 X 1 compressa | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 114 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - blister (ALU/ALU) - 28 compresse | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 115 | Aubagio 14 MG FILM-coated tablets | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 116 | AUTO-titrating oxygen system (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 85 85 💬
|
| 117 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | 1件: 211 211 💬
|
| 118 | Autologous CD34 positive cells transduced with A lentiviral vector containing human WAS gene | - | - | - | - | 1件: 65 65 💬
|
| 119 | Autologous CD34+ cells transduced with A lentiviral vector containing THE human sgsh gene | - | - | - | - | 1件: 19 19 💬
|
| 120 | Autologous CD34+ cells transduced with THE lentiviral vector containing THE human wiskott aldrich SY | - | - | - | - | 1件: 65 65 💬
|
| 121 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes FOR THE human wiskott aldrich syndrome (WAS) cdna sequence | - | - | - | - | 1件: 65 65 💬
|
| 122 | Autologous platelet-poor plasma (PPP) and thrombin coagulum treatment | - | - | - | - | 1件: 97 97 💬
|
| 123 | Autologous platelet-rich plasma (PRP) and thrombin coagulum treatment | - | - | - | - | 1件: 97 97 💬
|
| 124 | Autologous serum tears combined with 0.05% cyclosporin EYE drop | - | - | - | - | 1件: 53 53 💬
|
| 125 | Autologous umbilical cord blood | 1件: Autologous cord blood Autologous cord blood (Autologous cord blood) | - | - | - | 2件: 211 211, 294 💬
|
| 126 | Avonex - 30 MCG (6 milioni UI) polvere E solvente PER soluzione iniettabile 4 flaconi CON dispositivo bioset + 4 siringhe preriempite USO intramuscolare | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 127 | Avonex/betaseron/copaxone/rebif | - | - | - | - | 1件: 13 13 💬
|
| 128 | Azafor - 50 MG compresse rivestite CON film 50 compresse IN blister PVC/pvdc/AL | - | - | - | - | 1件: 97 97 💬
|
| 129 | Azathioprine + prednisolone (Delta-cortef) | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 95 95 💬
|
| 130 | Azatioprina aspen - 50 compresse | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 131 | Azilect 1 MG comprimidos | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 132 | Azithromycin + N-acetylcystein + inhaled corticosteroid | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 228 228 💬
|
| 133 | Azithromycin 500 MG FILM-coated tablet | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 299 299 💬
|
| 134 | B-peptide-CRM197 conjugate | - | - | - | - | 1件: 11 11 💬
|
| 135 | Bacillus coagulans | 1件: Bacillus coagulans Bacillus coagulans (Bacillus coagulans) | - | - | - | 1件: 6 6 💬
|
| 136 | Balance and coordination | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 121 121 💬
|
| 137 | Balance training BY means OF conventional rehabilitation | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 18 18 💬
|
| 138 | Balsalazide (Colazide, COLAZAL) | 1件: Balsalazide Balsalazide | 2件: Balsalazide disodium
Balsalazide disodium
(Colazide, COLAZAL),
Balsalazide
💬
| - | - | 1件: 97 97 💬
|
| 139 | Balsalazide disodium (Colazide, COLAZAL) | 1件: Balsalazide Balsalazide | 2件: Balsalazide disodium
Balsalazide disodium
(Colazide, COLAZAL),
Balsalazide
💬
| - | - | 1件: 97 97 💬
|
| 140 | Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem | - | - | - | - | 1件: 296 296 💬
|
| 141 | Bassado - 100 MG compresse 10 compresse | - | - | - | - | 1件: 28 28 💬
|
| 142 | BAY 63-2521 coated tablets 0.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 143 | BAY 63-2521 coated tablets 1 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 144 | BAY 63-2521 coated tablets 1.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 145 | BAY 63-2521 coated tablets 2 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 146 | BAY 63-2521 coated tablets 2.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 147 | BAY 63-2521 IR coated tablet 1.0 MG | - | - | - | - | 1件: 88 88 💬
|
| 148 | BAY 63-2521 IR coated tablet 1.5 MG | - | - | - | - | 1件: 88 88 💬
|
| 149 | BAY 63-2521 IR coated tablet 2.0 MG | - | - | - | - | 1件: 88 88 💬
|
| 150 | BAY 63-2521 IR coated tablet 2.5 MG | - | - | - | - | 1件: 88 88 💬
|
| 151 | BB-301: dose escalation phase 1B cohort 1 | 1件: BB-301 BB-301 | - | - | - | 1件: 113 113 💬
|
| 152 | BB-301: dose escalation phase 1B cohort 2 | 1件: BB-301 BB-301 | - | - | - | 1件: 113 113 💬
|
| 153 | BB-301: dose escalation phase 1B cohort 3 | 1件: BB-301 BB-301 | - | - | - | 1件: 113 113 💬
|
| 154 | Befizal L.P. 400 MG, comprimé enrobé à LIBération prolongéE | - | - | - | - | 1件: 94 94 💬
|
| 155 | Behavioral counseling | - | - | - | - | 1件: 97 97 💬
|
| 156 | Behavioral health consultation/therapy | - | - | - | - | 1件: 226 226 💬
|
| 157 | Benlysta 400 MG powder FOR concentrate FOR solution FOR infusion | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 43 43, 49 💬
|
| 158 | Benlysta 400 MG powder FOR concentrate FOR solution FOR infusions | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬
|
| 159 | Benlysta 400MG polvere PER concentrato PER soluzione PER infusione | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 43 43 💬
|
| 160 | Berberine (Coptis rhizome, Powdered coptis rhizome, Coptis rhizome) | 1件: Berberine Berberine | 1件: Coptis rhizome
Coptis rhizome
(Coptis rhizome, Powdered coptis rhizome, Coptis rhizome) 💬
| - | - | 3件: 46 46, 97, 265 💬
|
| 161 | Berberine chloride (Coptis rhizome, Powdered coptis rhizome, Coptis rhizome) | 1件: Berberine Berberine | 1件: Coptis rhizome
Coptis rhizome
(Coptis rhizome, Powdered coptis rhizome, Coptis rhizome) 💬
| - | - | 1件: 97 97 💬
|
| 162 | Berinert, lyophilizate FOR IV application containing 500 IU C1-INH TO BE reconstituted with 10 ML water FOR injection | 1件: Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | 1件: 65 65 💬
|
| 163 | Best medical treatment (BMT): adjustment OF THE dopaminergic medication and NON-dopaminergic therapy customized FOR each patient according TO THE latest published consensus group recommendations | - | - | - | - | 1件: 6 6 💬
|
| 164 | Best medical treatment FOR management OF impulse control IN parkinson´S disease according TO widely accepted expert consensus paper | - | - | - | - | 1件: 6 6 💬
|
| 165 | Bexsero - sospensione iniettabile - USO intramuscolare - siringa preriempita (vetro) - 0.5ML - 1 siringa preriempita CON AGO | - | - | - | - | 2件: 62 62, 66 💬
|
| 166 | BI 1015550 18 MG film coated tablet | - | - | - | - | 1件: 85 85 💬
|
| 167 | BI 1015550 9 MG film coated tablet | - | - | - | - | 1件: 85 85 💬
|
| 168 | BIIB033 (ANTI-lingo) - EV substance code SUB118957 | - | - | - | - | 1件: 13 13 💬
|
| 169 | Bilateral high frequency deep brain stimulation OF THE subthalamic neucleus combined with best medical treatment according TO widely accepted expert consensus paper | - | - | - | - | 1件: 6 6 💬
|
| 170 | Bilateral high frequency deep brainstimulation OF THE subthalamic nucleus combined with best medical treatment | - | - | - | - | 1件: 6 6 💬
|
| 171 | Biological: umbilical cord based allogenic mesenchymal stem cell | - | - | - | - | 1件: 113 113 💬
|
| 172 | Biopsy OF colon | - | - | - | - | 1件: 97 97 💬
|
| 173 | Biospecimen collection | - | - | - | - | 18件: 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 174 | Blokium 50 MG comprimidos | - | - | - | - | 1件: 167 167 💬
|
| 175 | Blood analysis FOR hypercalcemia'S control | - | - | - | - | 1件: 18 18 💬
|
| 176 | Blood coagulation factor viii and VWF, human | - | - | - | - | 1件: 288 288 💬
|
| 177 | Blood coagulation factor xiii | - | - | - | - | 1件: 51 51 💬
|
| 178 | Blood collection | - | - | - | - | 2件: 229 229, 271 💬
|
| 179 | Blood drawing IN healthy controls | - | - | - | - | 1件: 65 65 💬
|
| 180 | Blood or saliva sample collection | - | - | - | - | 3件: 96 96, 97, 299 💬
|
| 181 | Blood sample and cotton skin swabs | - | - | - | - | 1件: 162 162 💬
|
| 182 | Blood sample collection | - | - | - | - | 1件: 85 85 💬
|
| 183 | Blood samples collect | - | - | - | - | 1件: 234 234 💬
|
| 184 | Blood sampling and DNA collection | - | - | - | - | 1件: 6 6 💬
|
| 185 | Blood sampling from umbilical cord | - | - | - | - | 3件: 46 46, 96, 271 💬
|
| 186 | Body composition | - | - | - | - | 1件: 67 67 💬
|
| 187 | Body composition using A HAND-held body FAT monitor • resting metabolic rate (RMR) using A ventilated hood system | - | - | - | - | 1件: 8 8 💬
|
| 188 | Bone marrow concentrate | - | - | - | - | 1件: 70 70 💬
|
| 189 | Bone marrow or umbilical cord blood (UCG) stem cell transplantation | - | - | - | - | 1件: 36 36 💬
|
| 190 | Boots high strength garlic odour controlled | - | - | - | - | 1件: 299 299 💬
|
| 191 | Botulinum toxin A - haemagglutinin complex | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 192 | Bouchard belgian dark chocolate probiotic napolitains, containing bifidobacterium longum | - | - | - | - | 1件: 13 13 💬
|
| 193 | Breath test using THE compact PTR-TOF-MS | - | - | - | - | 2件: 89 89, 299 💬
|
| 194 | Brief resilient coping scale | - | - | - | - | 1件: 46 46 💬
|
| 195 | Bronchial mucus collection | - | - | - | - | 1件: 299 299 💬
|
| 196 | Bronchoalveolar lavage fluid collection | - | - | - | - | 1件: 229 229 💬
|
| 197 | Budesonide 0.5 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 198 | Budesonide 1 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 199 | Busilvex - 6 MG/ML - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 10 ML 8 flaconcini | 1件: Busulfan Busulfan | 1件: Busulfan
Busulfan
💬
| - | - | 2件: 19 19, 65 💬
|
| 200 | C-type natriuretic peptide conjugated TO A multi-ARM polyethylene glycol carrier molecule through A cleavable linker | - | - | - | - | 1件: 276 276 💬
|
| 201 | C-type natriuretic peptide conjugated TO multi-ARM polyethylene glycol carrier through A cleavable linker | - | - | - | - | 1件: 276 276 💬
|
| 202 | C1 esterase inhibitor concentrate | - | - | - | - | 1件: 65 65 💬
|
| 203 | C1 esterase inhibitor concentrate, human, pasteurized | - | - | - | - | 1件: 65 65 💬
|
| 204 | C1 inhibitor concentrate | 1件: Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | 1件: 65 65 💬
|
| 205 | C11 pittsburgh compound B | - | - | - | - | 1件: 13 13 💬
|
| 206 | Cabozantinib (Cometriq) | 1件: Cabozantinib Cabozantinib | 2件: Cabozantinib
Cabozantinib
(Cometriq),
Cabozantinib s-malate
(Cometriq, COMETRIQ) 💬
| 3件: AXL AXL, KDR, MET 💬
| 25件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 💬
|
| 207 | Cabozantinib oral tablet (Cometriq) | 1件: Cabozantinib Cabozantinib | 2件: Cabozantinib
Cabozantinib
(Cometriq),
Cabozantinib s-malate
(Cometriq, COMETRIQ) 💬
| 3件: AXL AXL, KDR, MET 💬
| 25件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 💬
|
| 208 | Calcio carbonato/colecalciferolo | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 274 274 💬
|
| 209 | Calcium and cholecalciferol (Colecalciferol) | 2件: Calcium Calcium, Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 46 46 💬
|
| 210 | Calcium and vitamin D combination | 1件: Calcium Calcium | - | - | - | 1件: 13 13 💬
|
| 211 | Calcium D3 sandoz - 1000 MG + 880 U.I. compresse effervescenti 30 compresse divisibili | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 274 274 💬
|
| 212 | Carbidopa and levodopa controlled release tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 213 | Carbidopa, levodopa, entacapone (Comtan, COMTAN) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 214 | Carbidopa/L-dopa/entacapone (Comtan, COMTAN) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan, COMTAN) 💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 215 | Carbidopa/levodopa/entacapone (Comtan, COMTAN) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 216 | Carbon dioxide insufflation during colonoscopy | 2件: Activated charcoal Activated charcoal, Carbon dioxide | 2件: Carbon dioxide
Carbon dioxide
,
Charcoal, activated
💬
| - | - | 1件: 97 97 💬
|
| 217 | Carvedilol (Coreg, COREG) | 1件: Carvedilol Carvedilol | 2件: Carvedilol
Carvedilol
(Coreg, COREG),
Carvedilol phosphate
(Coreg CR, COREG CR) 💬
| 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
| 15件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 46, 57, 86, 113, 210 💬
|
| 218 | Cawthorne cooksey exercises | - | - | - | - | 1件: 13 13 💬
|
| 219 | CBD - solution orale, conosciuto come epidiolex, questo è IL nome approvato negli stati uniti | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
| 220 | CBD soluzione orale nota come epidyolex E CON tale nome è stato approvato IN UE | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
| 221 | Cbdv compound | 1件: Cannabidivarin Cannabidivarin | - | - | - | 1件: 193 193 💬
|
| 222 | Cell suspension containing dendritic cells | - | - | - | - | 1件: 13 13 💬
|
| 223 | CELL-based EX-vivo assay with HIGH-content analysis | - | - | - | - | 1件: 41 41 💬
|
| 224 | Cellcept 500 MG comprimidos recubiertos | - | - | - | - | 1件: 35 35 💬
|
| 225 | Cellcept 500 MG FILM-coated tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 11 11 💬
|
| 226 | Cellcept®500 MG comprimidos | - | - | - | - | 1件: 35 35 💬
|
| 227 | Cellule CD34+ autologhe trasdotte CON idua LV codificante PER IL cdna dell'ALFA-L-iduronidasi | - | - | - | - | 1件: 19 19 💬
|
| 228 | Cellvizio 100 series system with confocal miniprobes | - | - | - | - | 1件: 215 215 💬
|
| 229 | Cerezyme 400 units powder FOR concentrate FOR solution FOR infusion | 1件: Imiglucerase Imiglucerase | 2件: Alglucerase
Alglucerase
,
Imiglucerase
💬
| 1件: GBA GBA 💬
| 4件: Cornified envelope formation Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 230 | Cerezyme 400 unità polvere PER concentrato PER soluzione PER infusione | - | - | - | - | 1件: 19 19 💬
|
| 231 | CFZ533 active - cohort 1 | - | - | - | - | 1件: 53 53 💬
|
| 232 | CFZ533 active - cohort 2 | - | - | - | - | 1件: 53 53 💬
|
| 233 | CFZ533 active - cohort 3 | - | - | - | - | 1件: 53 53 💬
|
| 234 | CFZ533 active -cohort 3 | - | - | - | - | 1件: 53 53 💬
|
| 235 | Characterization, evaluation and comparison OF macular pigment density | - | - | - | - | 1件: 264 264 💬
|
| 236 | Chicken type II collagen | 1件: Chicken Chicken | - | - | - | 1件: 46 46 💬
|
| 237 | Chinese herbal concoction twice A DAY FOR 6 months | - | - | - | - | 1件: 60 60 💬
|
| 238 | Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
|
| 239 | Cholecalciferol 10,000 IU (Colecalciferol) | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
| 240 | Cholecalciferol 400 IU (Colecalciferol) | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
| 241 | Cholecalciferol and C. xanthorrhiza (Colecalciferol) | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 49 49 💬
|
| 242 | Cholecalciferol concentrate | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
| 243 | Cholecalciferol pill (Colecalciferol) | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 💬
|
| 244 | Cholecalciferol, vitamin D3 (Colecalciferol) | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 13 13 💬
|
| 245 | Cholestyramine (Colestyramine) | 1件: Cholestyramine Cholestyramine (Colestyramine) | 1件: Cholestyramine resin
Cholestyramine resin
(Colestyramine) 💬
| - | - | 2件: 13 13, 79 💬
|
| 246 | Chronic corticosteroid therapy | - | - | - | - | 1件: 113 113 💬
|
| 247 | Cialis - 20 MG 2 compresse rivestite CON film IN blister USO orale | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 75 75, 77 💬
|
| 248 | Cialis 10 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 249 | Cialis 2.5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 250 | Cialis 20 MG comprimidos recubiertos CON PELícula | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 251 | Cialis 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 252 | Cialis 5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 253 | Circadin 2 MG comprimidos DE liberacióN prolongada | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬
|
| 254 | Claritromycin 500MG film coated tablets | - | - | - | - | 1件: 299 299 💬
|
| 255 | Clenbuterol (Contraspasmin) | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
(Contraspasmin) 💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 1 1, 2, 113, 256 💬
|
| 256 | Clenbuterol HCL (Contraspasmin) | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
(Contraspasmin) 💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 257 | Clenbuterol hydrochloride (Contraspasmin) | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
(Contraspasmin) 💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 258 | Clobetasol propionate (Cormax) | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
(Cormax),
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 162 💬
|
| 259 | Clobetasol propionate + methotrexate (Cormax) | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
(Cormax),
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
| 260 | Clobetasol propionate alone (Cormax) | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
(Cormax),
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
| 261 | Clobetasol propionate cream treatment (Cormax) | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
(Cormax),
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
| 262 | CO-14 | - | - | - | - | 1件: 13 13 💬
|
| 263 | CO-medication: synthetic dmards | - | - | - | - | 1件: 46 46 💬
|
| 264 | CO-transplantation OF FMT and pectin | - | - | - | - | 1件: 97 97 💬
|
| 265 | CO-trimoxazole | - | - | - | - | 1件: 85 85 💬
|
| 266 | CO2 laser | - | - | - | - | 1件: 51 51 💬
|
| 267 | Coaching sessions | - | - | - | - | 1件: 49 49 💬
|
| 268 | Coagadex | - | - | - | - | 2件: 28 28, 288 💬
|
| 269 | CoagulacióN factor viii | - | - | - | - | 1件: 288 288 💬
|
| 270 | Coagulation factor viii | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
| 271 | Coagulation factor xiii | 1件: Factor XIII (human) Factor XIII (human) (Factor XIII concentrate) | - | - | - | 1件: 288 288 💬
|
| 272 | Coamoxiclav | - | - | - | - | 1件: 97 97 💬
|
| 273 | Coarse wheat bran | - | - | - | - | 1件: 6 6 💬
|
| 274 | Cobalt | 1件: Cobalt Cobalt (Cobalto) | - | - | - | 1件: 46 46 💬
|
| 275 | Cobalt™ bone cement | 1件: Cobalt Cobalt (Cobalto) | - | - | - | 1件: 46 46 💬
|
| 276 | Cobamamide | 1件: Cobamamide Cobamamide (cobamamida) | 1件: Cobamamide
Cobamamide
(Cobamamide) 💬
| - | - | 1件: 299 299 💬
|
| 277 | Cobimetinib | 1件: Cobimetinib Cobimetinib (Cobimetinib fumarate) | 2件: Cobimetinib
Cobimetinib
(Cobimetinib),
Cobimetinib fumarate
(Cobimetinib fumarate, Cobimetinib hemifumarate, Cotellic, COTELLIC) 💬
| 2件: MAP2K1 MAP2K1, MAP2K2 💬
| 88件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 280 280 💬
|
| 278 | Cobiprostone | 1件: Cobiprostone Cobiprostone (Cobiprostone) | 1件: Cobiprostone
Cobiprostone
(Cobiprostone) 💬
| - | - | 1件: 46 46 💬
|
| 279 | Cobitolimod | 1件: Cobitolimod Cobitolimod (Cobitolimod) | 1件: Cobitolimod
Cobitolimod
(Cobitolimod) 💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
| 280 | Cobitolimod 250 MG | 1件: Cobitolimod Cobitolimod (Cobitolimod) | 1件: Cobitolimod
Cobitolimod
(Cobitolimod) 💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
| 281 | Cobitolimod 500 MG | 1件: Cobitolimod Cobitolimod (Cobitolimod) | 1件: Cobitolimod
Cobitolimod
(Cobitolimod) 💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
| 282 | Cobitolimod 500MG | 1件: Cobitolimod Cobitolimod (Cobitolimod) | 1件: Cobitolimod
Cobitolimod
(Cobitolimod) 💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
| 283 | Cocoa | 1件: Cocoa Cocoa (Cocoa) | - | - | - | 1件: 6 6 💬
|
| 284 | Coconut OIL | 2件: Coconut Coconut (Coconut), Coconut oil (Cocos Nucifera Oil) | 1件: Coconut oil
Coconut oil
(Coconut oil) 💬
| - | - | 1件: 13 13 💬
|
| 285 | Coconut OIL and epigallocatechin gallate | 2件: Coconut Coconut (Coconut), Coconut oil (Cocos Nucifera Oil) | 1件: Coconut oil
Coconut oil
(Coconut oil) 💬
| - | - | 1件: 13 13 💬
|
| 286 | COD liver OIL | 1件: Cod liver oil Cod liver oil (Cod liver oil) | 1件: Cod liver oil
Cod liver oil
(Cod liver oil, Cod liver oil) 💬
| - | - | 1件: 46 46 💬
|
| 287 | Code ATC:L01xc04 | - | - | - | - | 1件: 65 65 💬
|
| 288 | Coduse balance training and step square exercises | - | - | - | - | 1件: 13 13 💬
|
| 289 | Coenzym Q10 nanodispersion | - | - | - | - | 1件: 5 5 💬
|
| 290 | Coenzym Q10, ubiquinon, ubichinon | - | - | - | - | 1件: 5 5 💬
|
| 291 | Coenzyme Q | - | - | - | - | 1件: 13 13 💬
|
| 292 | Coenzyme Q-10 IN normal control subjects | 1件: Ubidecarenone Ubidecarenone (CoQ10) | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 86 86 💬
|
| 293 | Coenzyme Q-10 IN pulmonary hypertension subjects | 1件: Ubidecarenone Ubidecarenone (CoQ10) | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 86 86 💬
|
| 294 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone (CoQ10) | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 12件: 2 2, 5, 6, 8, 10, 46, 57, 107, 113, 193, 214, 215 💬
|
| 295 | Coenzyme Q10 and lisinopril | 1件: Ubidecarenone Ubidecarenone (CoQ10) | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 113 113 💬
|
| 296 | Coenzyme Q10 with vitamin E | 1件: Ubidecarenone Ubidecarenone (CoQ10) | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 6 6 💬
|
| 297 | Coenzymeq10 | - | - | - | - | 1件: 21 21 💬
|
| 298 | Coffee | - | - | - | - | 1件: 96 96 💬
|
| 299 | Coffee coal | - | - | - | - | 1件: 97 97 💬
|
| 300 | Coffee consumption | - | - | - | - | 1件: 46 46 💬
|
| 301 | Cognitive and behavioral experimental tasks | - | - | - | - | 1件: 127 127 💬
|
| 302 | Cognitive battery | - | - | - | - | 1件: 6 6 💬
|
| 303 | Cognitive evaluation | - | - | - | - | 1件: 8 8 💬
|
| 304 | Cognitive training | - | - | - | - | 1件: 206 206 💬
|
| 305 | Cohort 1 0.225G | - | - | - | - | 1件: 240 240 💬
|
| 306 | Cohort 1: 1.0 X 10^8 polytregs | - | - | - | - | 1件: 35 35 💬
|
| 307 | Cohort 1: hatg, CSA, epag DAY 14 TO month 6 | - | - | - | - | 1件: 60 60 💬
|
| 308 | Cohort 1: JMKX003142 and itraconazole | - | - | - | - | 1件: 67 67 💬
|
| 309 | Cohort 2 0.75G | - | - | - | - | 1件: 240 240 💬
|
| 310 | Cohort 2: 2.5x10^8 polytregs | - | - | - | - | 1件: 35 35 💬
|
| 311 | Cohort 2: hatg, CSA, epag DAY 14 TO month 3 | - | - | - | - | 1件: 60 60 💬
|
| 312 | Cohort 2: JMKX003142 and rifampicin | - | - | - | - | 1件: 67 67 💬
|
| 313 | Cohort 3 2.25 G | - | - | - | - | 1件: 240 240 💬
|
| 314 | Cohort 3: hatg, CSA (dose reduced), epag DAY 1 TO month 6 | - | - | - | - | 1件: 60 60 💬
|
| 315 | Cohort1 | - | - | - | - | 1件: 6 6 💬
|
| 316 | Cohort2 | - | - | - | - | 1件: 6 6 💬
|
| 317 | COL7a1-SIN retroviral vector engineered autologous tissue-engineered skin | - | - | - | - | 1件: 36 36 💬
|
| 318 | Colal pred | - | - | - | - | 1件: 97 97 💬
|
| 319 | Colal-pred | - | - | - | - | 1件: 97 97 💬
|
| 320 | Colchicina lirca - 1 MG compresse 60 compresse | 1件: Colchicine Colchicine (Colchicina) | 1件: Colchicine
Colchicine
(Colchicine, Colchicine, COLCHICINE, COLCRYS) 💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬
|
| 321 | Colchicine | 1件: Colchicine Colchicine (Colchicina) | 1件: Colchicine
Colchicine
(Colchicine, Colchicine, COLCHICINE, COLCRYS) 💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 8件: 42 42, 46, 50, 56, 93, 97, 210, 266 💬
|
| 322 | Colchicine 1 MG oral tablet | 1件: Colchicine Colchicine (Colchicina) | 1件: Colchicine
Colchicine
(Colchicine, Colchicine, COLCHICINE, COLCRYS) 💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬
|
| 323 | Colchicine cessation | 1件: Colchicine Colchicine (Colchicina) | 1件: Colchicine
Colchicine
(Colchicine, Colchicine, COLCHICINE, COLCRYS) 💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬
|
| 324 | Colchicine level measurement | 1件: Colchicine Colchicine (Colchicina) | 1件: Colchicine
Colchicine
(Colchicine, Colchicine, COLCHICINE, COLCRYS) 💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬
|
| 325 | Colchicine sprinkle capsules | 1件: Colchicine Colchicine (Colchicina) | 1件: Colchicine
Colchicine
(Colchicine, Colchicine, COLCHICINE, COLCRYS) 💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬
|
| 326 | Cold cadioplegia | - | - | - | - | 1件: 215 215 💬
|
| 327 | Colecalciferol | 1件: Cholecalciferol Cholecalciferol (Colecalciferol) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol) 💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 13 13, 46, 96, 97, 228 💬
|
| 328 | Colectomy | - | - | - | - | 1件: 97 97 💬
|
| 329 | Colesevelam | 1件: Colesevelam Colesevelam (Colesevelam hydrochloride) | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
(Colesevelam hydrochloride, COLESEVELAM HYDROCHLORIDE, COLESEVELAM, COLESEVELAM HCL),
Colesevelam
(Colesevelam) 💬
| - | - | 1件: 96 96 💬
|
| 330 | Colesevelam hydrochloride | 1件: Colesevelam Colesevelam (Colesevelam hydrochloride) | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
(Colesevelam hydrochloride, COLESEVELAM HYDROCHLORIDE, COLESEVELAM, COLESEVELAM HCL),
Colesevelam
(Colesevelam) 💬
| - | - | 1件: 79 79 💬
|
| 331 | Colesevelam hydrochloride FILM-coated tablets | 1件: Colesevelam Colesevelam (Colesevelam hydrochloride) | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
(Colesevelam hydrochloride, COLESEVELAM HYDROCHLORIDE, COLESEVELAM, COLESEVELAM HCL),
Colesevelam
(Colesevelam) 💬
| - | - | 1件: 79 79 💬
|
| 332 | Colestipol | 1件: Colestipol Colestipol (Colestipolum) | 2件: Colestipol hydrochloride
Colestipol hydrochloride
(Colestipol hydrochloride, Colestid, COLESTID, COLESTIPOL HYDROCHLORIDE),
Colestipol
(Colestipol) 💬
| - | - | 1件: 254 254 💬
|
| 333 | Colestiramina | 1件: Cholestyramine Cholestyramine (Colestyramine) | 1件: Cholestyramine resin
Cholestyramine resin
(Colestyramine) 💬
| - | - | 1件: 13 13 💬
|
| 334 | Colestyramine | 1件: Cholestyramine Cholestyramine (Colestyramine) | 1件: Cholestyramine resin
Cholestyramine resin
(Colestyramine) 💬
| - | - | 1件: 254 254 💬
|
| 335 | Colfinair 2 MIU powder FOR nebuliser solution | - | - | - | - | 1件: 299 299 💬
|
| 336 | Colimicina - 1000000 U/4 ML polvere E solvente PER soluzione iniettabile PER USO intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ML | - | - | - | - | 1件: 299 299 💬
|
| 337 | Colimycine inhalation | - | - | - | - | 1件: 299 299 💬
|
| 338 | Colimycine injectable | - | - | - | - | 1件: 299 299 💬
|
| 339 | Colistimetato sodico | - | - | - | - | 1件: 299 299 💬
|
| 340 | Colistimethat-natrium | - | - | - | - | 1件: 299 299 💬
|
| 341 | Colistimethate | 1件: Colistimethate Colistimethate (Colistimethate sodium) | 1件: Colistimethate sodium
Colistimethate sodium
(Colistimethate sodium, Colistin sodium methanesulfonate, Coly-Mycin M, COLY-MYCIN, COLISTIMETHATE, COLISTIMETHATE SODIUM) 💬
| - | - | 1件: 299 299 💬
|
| 342 | Colistimethate 75 MG inhaled TWO times daily | 1件: Colistimethate Colistimethate (Colistimethate sodium) | 1件: Colistimethate sodium
Colistimethate sodium
(Colistimethate sodium, Colistin sodium methanesulfonate, Coly-Mycin M, COLY-MYCIN, COLISTIMETHATE, COLISTIMETHATE SODIUM) 💬
| - | - | 1件: 299 299 💬
|
| 343 | Colistimethate sodium | 1件: Colistimethate Colistimethate (Colistimethate sodium) | 1件: Colistimethate sodium
Colistimethate sodium
(Colistimethate sodium, Colistin sodium methanesulfonate, Coly-Mycin M, COLY-MYCIN, COLISTIMETHATE, COLISTIMETHATE SODIUM) 💬
| - | - | 1件: 299 299 💬
|
| 344 | Colistimethate sodium (BAN, usan), colistimethatum natricum, colistin sodium methanesulfonate | 1件: Colistimethate Colistimethate (Colistimethate sodium) | 1件: Colistimethate sodium
Colistimethate sodium
(Colistimethate sodium, Colistin sodium methanesulfonate, Coly-Mycin M, COLY-MYCIN, COLISTIMETHATE, COLISTIMETHATE SODIUM) 💬
| - | - | 1件: 299 299 💬
|
| 345 | Colistin | 1件: Colistin Colistin (Colistine) | 2件: Colistin sulfate
Colistin sulfate
(Colistin sulfate, Coly-Mycin S, Colymycin S),
Colistin
(Colistin) 💬
| - | - | 1件: 299 299 💬
|
| 346 | Colistin CF | 1件: Colistin Colistin (Colistine) | 2件: Colistin sulfate
Colistin sulfate
(Colistin sulfate, Coly-Mycin S, Colymycin S),
Colistin
(Colistin) 💬
| - | - | 1件: 299 299 💬
|
| 347 | Colistin forest - trockenstechampullen MIT Lösungsmittel | 1件: Colistin Colistin (Colistine) | 2件: Colistin sulfate
Colistin sulfate
(Colistin sulfate, Coly-Mycin S, Colymycin S),
Colistin
(Colistin) 💬
| - | - | 1件: 299 299 💬
|
| 348 | Colistin mesilate sodium | 1件: Colistin Colistin (Colistine) | 2件: Colistin sulfate
Colistin sulfate
(Colistin sulfate, Coly-Mycin S, Colymycin S),
Colistin
(Colistin) 💬
| - | - | 1件: 299 299 💬
|
| 349 | Colistineb 2MUI | - | - | - | - | 1件: 299 299 💬
|
| 350 | Collagenase | 1件: Collagenase clostridium histolyticum Collagenase clostridium histolyticum (Collagenase) | 1件: Collagenase clostridium histolyticum
Collagenase clostridium histolyticum
(Collagenase clostridium histolyticum, Collagenase, Collagenase clostridium histolyticum-aaes, Collagenase santyl, COLLAGENASE SANTYL) 💬
| - | - | 1件: 162 162 💬
|
| 351 | Collect OF 10 ML OF peripheric blood FOR DNA extraction | - | - | - | - | 1件: 46 46 💬
|
| 352 | Collection OF arterial pressure, metabolic data, kidney function, proteinuria and hematuria before and after katrio initiation | - | - | - | - | 1件: 299 299 💬
|
| 353 | Collection OF biological samples | - | - | - | - | 1件: 63 63 💬
|
| 354 | Collection OF blood and urine | - | - | - | - | 1件: 25 25 💬
|
| 355 | Collection OF CSF, blood, urine, saliva | - | - | - | - | 1件: 6 6 💬
|
| 356 | Collection OF samples | - | - | - | - | 4件: 49 49, 65, 95, 107 💬
|
| 357 | Collection OF samples OF blood and urine | - | - | - | - | 1件: 167 167 💬
|
| 358 | Colobreathe | 1件: Colistimethate Colistimethate (Colistimethate sodium) | 1件: Colistimethate sodium
Colistimethate sodium
(Colistimethate sodium, Colistin sodium methanesulfonate, Coly-Mycin M, COLY-MYCIN, COLISTIMETHATE, COLISTIMETHATE SODIUM) 💬
| - | - | 1件: 299 299 💬
|
| 359 | Colomycin | - | - | - | - | 1件: 299 299 💬
|
| 360 | Colon KCC heptapeptide | - | - | - | - | 1件: 97 97 💬
|
| 361 | Colon preparation FOR colonoscopy | - | - | - | - | 1件: 97 97 💬
|
| 362 | Colonic lavage | - | - | - | - | 1件: 291 291 💬
|
| 363 | Colonoscopy | - | - | - | - | 2件: 96 96, 97 💬
|
| 364 | Colonoscopy with indigo-carmine chromoendoscopy | - | - | - | - | 1件: 97 97 💬
|
| 365 | Color fundus photography | - | - | - | - | 1件: 41 41 💬
|
| 366 | Colorectal biopsies | - | - | - | - | 1件: 97 97 💬
|
| 367 | Colored water | - | - | - | - | 1件: 97 97 💬
|
| 368 | Colovit capsule | - | - | - | - | 1件: 96 96 💬
|
| 369 | Coltect | - | - | - | - | 1件: 97 97 💬
|
| 370 | Combination antiviral therapy | - | - | - | - | 1件: 93 93 💬
|
| 371 | Combination fish OIL and borage seed OIL | 1件: Fish oil Fish oil | - | - | - | 1件: 46 46 💬
|
| 372 | Combination injection OF EPO and G-CSF | - | - | - | - | 1件: 6 6 💬
|
| 373 | Combination OF A single dose ANTI-CD20 antibody and bortezomib | - | - | - | - | 1件: 61 61 💬
|
| 374 | Combination OF dmards | - | - | - | - | 1件: 107 107 💬
|
| 375 | Combination OF fish OIL and colesevelam | - | - | - | - | 1件: 260 260 💬
|
| 376 | Combination OF minocycline and MTX or MTX alone | - | - | - | - | 1件: 46 46 💬
|
| 377 | Combination OF navepegritide and lonapegsomatropin administered AS TWO separate S.C. injections | - | - | - | - | 1件: 276 276 💬
|
| 378 | Combination OF protein A immunoadsorption, rituximab, dexamethasone plus azathioprine | - | - | - | - | 1件: 35 35 💬
|
| 379 | Combination OF rituximab with subcutaneous belimumab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬
|
| 380 | Combination OF thrombopoietin mimetic and cyclosporin A | - | - | - | - | 1件: 60 60 💬
|
| 381 | Combination oral budesonide and rectal hydrocortisone | - | - | - | - | 1件: 97 97 💬
|
| 382 | Combination steroid | - | - | - | - | 1件: 46 46 💬
|
| 383 | Combination therapy with vigabatrin and prednisolone | 1件: Vigabatrin Vigabatrin | 1件: Vigabatrin
Vigabatrin
💬
| 1件: ABAT ABAT 💬
| 6件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 145 145 💬
|
| 384 | Combination with dopamine agonist cabergoline | - | - | - | - | 1件: 77 77 💬
|
| 385 | Combination with somatostatin analogue octreotide | - | - | - | - | 1件: 77 77 💬
|
| 386 | Combined balance and brisk walking training | - | - | - | - | 1件: 6 6 💬
|
| 387 | Combined plasma exchange (PEX), rituximab, and corticosteroids | - | - | - | - | 1件: 85 85 💬
|
| 388 | Combined therapy OF iguratimod and tofacitinib | - | - | - | - | 1件: 46 46 💬
|
| 389 | Combivir | 2件: Lamivudine Lamivudine, Zidovudine | 2件: Lamivudine
Lamivudine
,
Zidovudine
💬
| - | - | 1件: 265 265 💬
|
| 390 | Comirnaty | - | - | - | - | 2件: 46 46, 51 💬
|
| 391 | Comirnaty concentrate FOR dispersion FOR injection | 1件: Tozinameran Tozinameran (Pfizer-BioNTech COVID-19 Vaccine) | 1件: Tozinameran
Tozinameran
(COVID-19 mRNA vaccine, Comirnaty, Pfizer-biontech Covid-19 vaccine, COMIRNATY) 💬
| - | - | 2件: 53 53, 299 💬
|
| 392 | Comirnaty konzentrat ZUR herstellung einer injektionsdispersion | - | - | - | - | 1件: 13 13 💬
|
| 393 | Commercial formulation etanercept | - | - | - | - | 1件: 46 46 💬
|
| 394 | Common name: sialic acid | - | - | - | - | 1件: 30 30 💬
|
| 395 | Communicative effectiveness survey | - | - | - | - | 1件: 2 2 💬
|
| 396 | Companion diagnostic (CDX) testing | - | - | - | - | 1件: 97 97 💬
|
| 397 | Comparative efficacy and safety OF thalidomide and sulfasalazine IN moderate TO severe ankylosing spondylitis: A REAL-world study from bangladesh | - | - | - | - | 1件: 271 271 💬
|
| 398 | Comparator | - | - | - | - | 1件: 96 96 💬
|
| 399 | Comparators | - | - | - | - | 1件: 54 54 💬
|
| 400 | Complement C1 esterase inhibitor | 1件: Conestat alfa Conestat alfa (Recombinant complement C1 esterase inhibitor) | 1件: Conestat alfa
Conestat alfa
(Conestat alfa) 💬
| 3件: C1R C1R, C1S, KLKB1 💬
| 6件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 61 61, 65 💬
|
| 401 | Complement protein C5 inhibitor | - | - | - | - | 1件: 13 13 💬
|
| 402 | Complete physical examination | - | - | - | - | 1件: 113 113 💬
|
| 403 | Complete, polymeric formula, fiber, lactose and gluten free | - | - | - | - | 1件: 107 107 💬
|
| 404 | Complex task practice | - | - | - | - | 1件: 6 6 💬
|
| 405 | Compound 1A | - | - | - | - | 2件: 246 246, 299 💬
|
| 406 | Compound 21 | 1件: Buloxibutid Buloxibutid (COMPOUND 21) | 2件: Buloxibutid
Buloxibutid
,
Buloxibutid sodium
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 407 | Compound thrombosis capsule SIG: 1.5G/TID | - | - | - | - | 1件: 90 90 💬
|
| 408 | Compressa effervescente 0,5 MG DI budesonide PER USO orodispersibile | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 409 | Compressa effervescente 1 MG DI budesonide PER USO orodispersibile | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 410 | Compressed oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 97 97 💬
|
| 411 | Computed tomography | - | - | - | - | 12件: 26 26, 28, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
| 412 | Computed tomography lung subtraction iodine mapping | - | - | - | - | 1件: 88 88 💬
|
| 413 | Computer game based balance and walking rehabilitation FOR individuals with parkinson'S disease | - | - | - | - | 1件: 6 6 💬
|
| 414 | Computer-assisted telephone interview | - | - | - | - | 1件: 85 85 💬
|
| 415 | Computerized tomography scan | - | - | - | - | 1件: 98 98 💬
|
| 416 | Comtan | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
(Comtan, COMTAN) 💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 417 | Comtan 200* 60 CPR 200 MG | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
(Comtan, COMTAN) 💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 418 | Comtess | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
(Comtan, COMTAN) 💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 419 | Concerta | - | - | - | - | 1件: 203 203 💬
|
| 420 | Concomitant medication | - | - | - | - | 1件: 49 49 💬
|
| 421 | Concurrent exercise training | - | - | - | - | 1件: 113 113 💬
|
| 422 | Conestat alfa | 1件: Conestat alfa Conestat alfa (Recombinant complement C1 esterase inhibitor) | 1件: Conestat alfa
Conestat alfa
(Conestat alfa) 💬
| 3件: C1R C1R, C1S, KLKB1 💬
| 6件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 65 65 💬
|
| 423 | Confirm RX | - | - | - | - | 1件: 86 86 💬
|
| 424 | Confortid | - | - | - | - | 1件: 225 225 💬
|
| 425 | Conjugated equine estrogens 0.625 MG/D + MPA 5 MG/D/10D | 1件: Conjugated estrogens Conjugated estrogens (Conjugated estrogens) | 1件: Estrogens, conjugated
Estrogens, conjugated
(Estrogens, conjugated, Conjugated estrogens) 💬
| - | - | 1件: 49 49 💬
|
| 426 | Conscious sedation | - | - | - | - | 1件: 6 6 💬
|
| 427 | Conservative measures FOR orthostatic hypotension | - | - | - | - | 2件: 6 6, 17 💬
|
| 428 | Conservative rehabilitation | - | - | - | - | 1件: 149 149 💬
|
| 429 | Conservative treatment | - | - | - | - | 1件: 291 291 💬
|
| 430 | Continuation OF azathioprine | - | - | - | - | 1件: 49 49 💬
|
| 431 | Continue their usual therapy | - | - | - | - | 1件: 66 66 💬
|
| 432 | Continued ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
| 433 | Continuous apomorphine infusion | - | - | - | - | 1件: 6 6 💬
|
| 434 | Continuous glucose monitor | - | - | - | - | 2件: 65 65, 298 💬
|
| 435 | Continuous glucose monitoring | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 2件: 75 75, 299 💬
|
| 436 | Continuous infusion cefepime | - | - | - | - | 1件: 299 299 💬
|
| 437 | Continuous infusion ceftazidime | - | - | - | - | 1件: 299 299 💬
|
| 438 | Continuous infusion meropenem | - | - | - | - | 1件: 299 299 💬
|
| 439 | Continuous infusion piperacillin tazobactam | - | - | - | - | 1件: 299 299 💬
|
| 440 | Continuous infusion ticarcillin-clavulanate | - | - | - | - | 1件: 299 299 💬
|
| 441 | Continuous intrajejunal infusion OF levodopa-carbidopa | - | - | - | - | 1件: 6 6 💬
|
| 442 | Continuous oxygen | - | - | - | - | 1件: 90 90 💬
|
| 443 | Continuous release dopamine agonists | - | - | - | - | 1件: 6 6 💬
|
| 444 | Continuous subcutaneous lisuride infusion | - | - | - | - | 1件: 6 6 💬
|
| 445 | Contrast enhanced ultrasound | - | - | - | - | 1件: 96 96 💬
|
| 446 | Contrast enhanced voiding urosonography with urodynamic testing | - | - | - | - | 1件: 118 118 💬
|
| 447 | Contrast media, magnetic resonance | - | - | - | - | 2件: 94 94, 96 💬
|
| 448 | Contrast sensitivity measurement | - | - | - | - | 1件: 19 19 💬
|
| 449 | Contrast-enhanced ultrasound | - | - | - | - | 1件: 41 41 💬
|
| 450 | Control diet | - | - | - | - | 2件: 96 96, 97 💬
|
| 451 | Control GEL | - | - | - | - | 1件: 36 36 💬
|
| 452 | Control group 0.9% isotonic saline | - | - | - | - | 1件: 299 299 💬
|
| 453 | Control group typically developing | - | - | - | - | 1件: 113 113 💬
|
| 454 | Control group: mesalazine enema treatment | - | - | - | - | 1件: 97 97 💬
|
| 455 | Control multivitamin | - | - | - | - | 1件: 299 299 💬
|
| 456 | Control surgery | - | - | - | - | 1件: 6 6 💬
|
| 457 | Control wound treatment | - | - | - | - | 1件: 36 36 💬
|
| 458 | Controlled-release levodopa / carbidopa | - | - | - | - | 1件: 6 6 💬
|
| 459 | Convection enhanced delivery/AAV2-gdnf | - | - | - | - | 1件: 6 6 💬
|
| 460 | Conventional | - | - | - | - | 1件: 63 63 💬
|
| 461 | Conventional balance exercise | - | - | - | - | 1件: 6 6 💬
|
| 462 | Conventional balance training | - | - | - | - | 1件: 13 13 💬
|
| 463 | Conventional dmard combination | - | - | - | - | 1件: 46 46 💬
|
| 464 | Conventional dmards | - | - | - | - | 1件: 46 46 💬
|
| 465 | Conventional drugs | - | - | - | - | 1件: 97 97 💬
|
| 466 | Conventional IBD medical treatment | - | - | - | - | 1件: 97 97 💬
|
| 467 | Conventional medication | - | - | - | - | 1件: 6 6 💬
|
| 468 | Conventional pharmacotherapy | - | - | - | - | 1件: 49 49 💬
|
| 469 | Conventional physiotherapy | - | - | - | - | 1件: 6 6 💬
|
| 470 | Conventional surgery | - | - | - | - | 1件: 34 34 💬
|
| 471 | Conventional synthetic antirheumatic drugs | - | - | - | - | 1件: 46 46 💬
|
| 472 | Conventional synthetic dmard | - | - | - | - | 1件: 46 46 💬
|
| 473 | Conventional therapy | - | - | - | - | 5件: 6 6, 49, 67, 97, 222 💬
|
| 474 | Conventional therapy users FOR THE last 5 years | - | - | - | - | 1件: 271 271 💬
|
| 475 | Conventional treatment | - | - | - | - | 2件: 96 96, 97 💬
|
| 476 | Conventional white-light colonoscopy | - | - | - | - | 1件: 97 97 💬
|
| 477 | Coolonic biopsies | - | - | - | - | 2件: 96 96, 97 💬
|
| 478 | Coozar | - | - | - | - | 1件: 167 167 💬
|
| 479 | COP-1/copolymer-1 | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 480 | Copanlisib | 1件: Copanlisib Copanlisib (Copanlisib) | 1件: Copanlisib
Copanlisib
(Copanlisib) 💬
| 2件: PIK3CA_B_D PIK3CA_B_D, PIK3CA_B_D 💬
| 103件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 121 121 💬
|
| 481 | Copaxone | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 482 | Copaxone - 20 MG/ML soluzione iniettabile 28 siringhe preriempite | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 483 | Copaxone - 20 MG/ML soluzione iniettabile IN siringhe preriempite 30 siringhe | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 484 | Copaxone - 40 MG/ML soluzione iniettabile IN | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 485 | Copaxone - 40 MG/ML soluzione iniettabile IN siringa preriempita 12 siringhe preriempite DA 1 ML CON AGO | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 486 | Copaxone 20 MG | - | - | - | - | 1件: 13 13 💬
|
| 487 | Copaxone 20 MG/ML | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 488 | Copaxone 20 MG/ML solucióN inyectable EN jeringa precargada | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 489 | Copaxone 20 MG/ML solucióN para inyeccióN EN jeringa precargada | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 490 | Copaxone 20 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 491 | Copaxone 20 MG/ML, solution FOR injection, PRE-filled syringes | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 492 | Copaxone 20MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 493 | Copaxone 40 MG/ML | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 494 | Copaxone 40 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 495 | Copaxone*SC 28SIR 20MG/ML | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 496 | Copaxone-teva | - | - | - | - | 1件: 13 13 💬
|
| 497 | Copegus | 1件: Ribavirin Ribavirin | 1件: Ribavirin
Ribavirin
(Copegus) 💬
| - | - | 1件: 2 2 💬
|
| 498 | Copolymer 1 | - | - | - | - | 1件: 13 13 💬
|
| 499 | Copper | 1件: Copper Copper (cobre) | - | - | - | 2件: 169 169, 171 💬
|
| 500 | Copper (64CU) chloride | 1件: Copper Copper (cobre) | - | - | - | 1件: 171 171 💬
|
| 501 | Copper histidinate | 1件: Copper Copper (cobre) | - | - | - | 1件: 169 169 💬
|
| 502 | Copper histidine | 2件: Copper Copper (cobre), Histidine (Copper histidine) | 1件: Histidine
Histidine
💬
| - | - | 2件: 169 169, 170 💬
|
| 503 | COQ10 | 1件: Ubidecarenone Ubidecarenone (CoQ10) | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 4件: 5 5, 6, 8, 96 💬
|
| 504 | Coqun | - | - | - | - | 1件: 90 90 💬
|
| 505 | COR-003 | - | - | - | - | 1件: 75 75 💬
|
| 506 | Cord blood | - | - | - | - | 1件: 60 60 💬
|
| 507 | Cord blood infusion | - | - | - | - | 1件: 60 60 💬
|
| 508 | Cord blood sampling | - | - | - | - | 1件: 227 227 💬
|
| 509 | Cord blood transplant | - | - | - | - | 1件: 60 60 💬
|
| 510 | Cord blood units | - | - | - | - | 1件: 60 60 💬
|
| 511 | Cord sampling | - | - | - | - | 1件: 227 227 💬
|
| 512 | Core stability | - | - | - | - | 1件: 13 13 💬
|
| 513 | Core stabilization exercises | - | - | - | - | 1件: 6 6 💬
|
| 514 | Cormeto - 250 MG capsule molli 50 capsule IN flacone hdpe | - | - | - | - | 1件: 75 75 💬
|
| 515 | Corn OIL capsules | 1件: Corn Corn (Corn) | - | - | - | 1件: 46 46 💬
|
| 516 | Corn starch | 1件: Starch, corn Starch, corn (Cornstarch) | 1件: Corn starch
Corn starch
(Corn starch, Starch, corn, Corn starch) 💬
| - | - | 2件: 49 49, 97 💬
|
| 517 | Corn/SOY OIL | 1件: Corn Corn (Corn) | - | - | - | 1件: 240 240 💬
|
| 518 | Cornstarch | 1件: Starch, corn Starch, corn (Cornstarch) | 1件: Corn starch
Corn starch
(Corn starch, Starch, corn, Corn starch) 💬
| - | - | 1件: 257 257 💬
|
| 519 | Cornstarch control | 1件: Starch, corn Starch, corn (Cornstarch) | 1件: Corn starch
Corn starch
(Corn starch, Starch, corn, Corn starch) 💬
| - | - | 1件: 90 90 💬
|
| 520 | CORT113176 | - | - | - | - | 1件: 2 2 💬
|
| 521 | CORT125134 | 1件: Relacorilant Relacorilant (CORT125134) | 1件: Relacorilant
Relacorilant
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 💬
|
| 522 | Cortancyl | 1件: Prednisone acetate Prednisone acetate (Cortancyl) | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 523 | Cortancyl 20 MG | 1件: Prednisone acetate Prednisone acetate (Cortancyl) | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 💬
|
| 524 | Cortancyl ® 1 MG | 1件: Prednisone acetate Prednisone acetate (Cortancyl) | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 525 | Cortancyl ® 20 MG | 1件: Prednisone acetate Prednisone acetate (Cortancyl) | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 526 | Cortancyl ® 5 MG | 1件: Prednisone acetate Prednisone acetate (Cortancyl) | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 527 | Cortecosteroid | - | - | - | - | 1件: 96 96 💬
|
| 528 | Cortef | - | - | - | - | 2件: 81 81, 83 💬
|
| 529 | Cortef 10MG | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 530 | Cortef 5 MG | - | - | - | - | 1件: 83 83 💬
|
| 531 | Cortef 5MG | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 532 | Corticoids+ tocilizumab 8MG/KG/4 weeks | - | - | - | - | 1件: 41 41 💬
|
| 533 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
| 534 | Corticosteroid and azathioprine | - | - | - | - | 4件: 42 42, 43, 44, 45 💬
|
| 535 | Corticosteroid injection | - | - | - | - | 1件: 46 46 💬
|
| 536 | Corticosteroid or nsaid | - | - | - | - | 1件: 46 46 💬
|
| 537 | Corticosteroide | - | - | - | - | 1件: 113 113 💬
|
| 538 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
|
| 539 | Corticosteroids & tancart19/20 | - | - | - | - | 1件: 13 13 💬
|
| 540 | Corticosteroids and immunosuppressants | - | - | - | - | 1件: 55 55 💬
|
| 541 | Corticosteroids combined with immunoglobulin and romiplostim | - | - | - | - | 1件: 63 63 💬
|
| 542 | Corticosteroids FOR systemic USE | - | - | - | - | 1件: 41 41 💬
|
| 543 | Corticosteroids only | - | - | - | - | 1件: 97 97 💬
|
| 544 | Corticosteroids'therapy | - | - | - | - | 1件: 35 35 💬
|
| 545 | Corticotherapy | - | - | - | - | 1件: 66 66 💬
|
| 546 | Corticotrophin 80 units | 1件: Corticotropin Corticotropin (Corticotrophin) | 2件: Corticotropin
Corticotropin
(Corticotropin, PURIFIED CORTROPHIN GEL),
Corticotropin, repository
(Corticotropin, repository, Cortigel) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 46 46 💬
|
| 547 | Corticotropin | 1件: Corticotropin Corticotropin (Corticotrophin) | 2件: Corticotropin
Corticotropin
(Corticotropin, PURIFIED CORTROPHIN GEL),
Corticotropin, repository
(Corticotropin, repository, Cortigel) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 78 78, 81 💬
|
| 548 | Corticotropin-releasing hormone | 2件: Corticorelin Corticorelin (Corticotropin-releasing hormone), Corticotropin (Corticotrophin) | 3件: Corticotropin
Corticotropin
(Corticotropin, PURIFIED CORTROPHIN GEL),
Corticorelin
(Corticorelin),
Corticotropin, repository
(Corticotropin, repository, Cortigel) 💬
| 3件: CRHR1 CRHR1, CRHR2, MC2R 💬
| 7件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 75 75, 205 💬
|
| 549 | Cortimentmmx 9 MG | - | - | - | - | 1件: 97 97 💬
|
| 550 | Cortisol | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 551 | Cortisol level | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 552 | Cortison | - | - | - | - | 1件: 81 81 💬
|
| 553 | Cortisone acetate | 3件: Cortisone Cortisone (Cortisona), Cortisone acetate (Cortisone acetate), Hydrocortisone (Cortisol) | 3件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA),
Cortisone acetate
(Cortisone acetate, Cortone acetate),
Cortisone
(Cortisone, Cortisone) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 554 | Cosentyx | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 4件: 41 41, 107, 269, 271 💬
|
| 555 | Cosentyx - 150 MG - soluzione iniettabile IN siringa preriempita -USO sottocutaneo - siringa (vetro) 1 ML (150MG/ML)- 2 siringhe preriempite | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 107 107 💬
|
| 556 | Cosentyx 300 MG solution FOR injection IN PRE-filled syringe | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
| 557 | Cosentyx 300MG solution FOR injection IN PRE-filled syringe | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
| 558 | Cosintropina acetato | - | - | - | - | 1件: 113 113 💬
|
| 559 | Cosmofer | - | - | - | - | 2件: 96 96, 97 💬
|
| 560 | Cosmofer 50MG/ML solution FOR infusion or injection | - | - | - | - | 2件: 96 96, 97 💬
|
| 561 | Costicosteroids | - | - | - | - | 1件: 26 26 💬
|
| 562 | Cosyntropin | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
| 563 | Cosyntropin acetate | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
| 564 | Cosyntropin injectable suspension 1 MG/ML + vigabatrin | 2件: Tetracosactide Tetracosactide (beta-corticotrophin), Vigabatrin | 3件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Vigabatrin
,
Tetracosactide acetate
(Cortrosyn) 💬
| 2件: ABAT ABAT, MC2R 💬
| 12件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Hormone signaling, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | 1件: 145 145 💬
|
| 565 | Cosyntropin injectable suspension, 1 MG/ML | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 145 145 💬
|
| 566 | Cosyntropin stimulation test | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 83 83 💬
|
| 567 | Cotoretigene toliparvovec | 1件: Cotoretigene toliparvovec Cotoretigene toliparvovec (Adeno-associated viral vector serotype 8 containing the human RPGR gene) | - | - | - | 1件: 90 90 💬
|
| 568 | Cotrimoxazole | - | - | - | - | 2件: 85 85, 97 💬
|
| 569 | Cotton gauze with petrolatum | 1件: Cotton Cotton (Cotton) | - | - | - | 2件: 35 35, 162 💬
|
| 570 | Cough monitor | - | - | - | - | 1件: 85 85 💬
|
| 571 | Coversin | 1件: Nomacopan Nomacopan (COVERSIN) | 1件: Nomacopan
Nomacopan
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 💬
|
| 572 | Coversyl | 1件: Perindopril Perindopril | 3件: Perindopril erbumine
Perindopril erbumine
,
Perindopril
,
Perindopril arginine
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 167 167 💬
|
| 573 | Coversyl plus | - | - | - | - | 1件: 19 19 💬
|
| 574 | Covid-19 vaccination | - | - | - | - | 1件: 13 13 💬
|
| 575 | Covid-19 vaccine | - | - | - | - | 5件: 13 13, 46, 49, 51, 97 💬
|
| 576 | Covid-19 vaccine astrazeneca | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine (Coronavirus Disease vaccine ChAdOx1 nCoV-19) | - | - | - | 2件: 46 46, 51 💬
|
| 577 | Covid-19 vaccine janssen suspension FOR injection | - | - | - | - | 1件: 299 299 💬
|
| 578 | Covid-19 vaccine moderna | - | - | - | - | 4件: 46 46, 51, 65, 272 💬
|
| 579 | Covid-19 vaccine moderna dispersion FOR injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine (MRNA-1273 SARS-COV-2) | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine, Covid-19 vaccine, Moderna Covid-19 vaccine) 💬
| - | - | 1件: 299 299 💬
|
| 580 | Covid-19 vaccines AT A 3-month interval | - | - | - | - | 2件: 46 46, 97 💬
|
| 581 | Covid-19 vaccines AT A 6-month interval | - | - | - | - | 2件: 46 46, 97 💬
|
| 582 | Covid19 vaccine | - | - | - | - | 1件: 13 13 💬
|
| 583 | Cozaar | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
| 584 | Cozaar 50 | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
| 585 | Cozaar 50 MG comprimidos recubierto CON pelicula | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 179 179 💬
|
| 586 | Cozaar inicio 12,5 MG comprimidos recubiertos CON pelicula | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
| 587 | Cpap group: postoperative cpap support, NON-cpap group: oxygen 3 liters PER minute (L/MIN) either VIA mask FOR those WHO were extubated or through A T-piece FOR those with A trash (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 330 330 💬
|
| 588 | Crestor FILM-coated tablet | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 💬
|
| 589 | Crestor tablets (calcium rosuvastatin) FILM-coated tablets | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 💬
|
| 590 | Cryopreserved autologous CD34+ cells transduced with A lentiviral vector containing human sgsh gene | - | - | - | - | 1件: 19 19 💬
|
| 591 | CS (corticosteroids) only | - | - | - | - | 1件: 97 97 💬
|
| 592 | Cumulative corticosteroid exposure | - | - | - | - | 1件: 49 49 💬
|
| 593 | Cuprior 150 MG FILM-coated tablets | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
| 594 | Cuprior 150MG FILM-coated tablets | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
| 595 | Curie artificial intelligence (AI) cough monitor | - | - | - | - | 1件: 299 299 💬
|
| 596 | Currently available therapy IN THE community | - | - | - | - | 1件: 51 51 💬
|
| 597 | Cushing'S syndrome confirmation | - | - | - | - | 1件: 75 75 💬
|
| 598 | Cyclophosphamide/glatiramer acetate (Copaxone, COPAXONE) | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
| 599 | Cyclosporine combine with mycophenolate mofetil | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 283 283 💬
|
| 600 | Cystic fibrosis transmembrane conductance regulator | 1件: Cystic fibrosis transmembrane conductance regulator Cystic fibrosis transmembrane conductance regulator (Cystic fibrosis transmembrane conductance regulator) | - | - | - | 1件: 299 299 💬
|
| 601 | Cytotoxic combination | - | - | - | - | 1件: 56 56 💬
|
| 602 | D-methylphenidate (Concerta, CONCERTA, COTEMPLA XR-ODT) | - | - | - | - | 1件: 84 84 💬
|
| 603 | D-sorbitol (Sorbitol 3% in plastic container) | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
(Sorbitol 3% in plastic container) 💬
| - | - | 1件: 10 10 💬
|
| 604 | Daratumumab and corticosteroid treatment | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 288 288 💬
|
| 605 | Data collection | - | - | - | - | 2件: 65 65, 299 💬
|
| 606 | Data collection FOR correlation between clinical defined and LAB defined GC responsivness | - | - | - | - | 1件: 41 41 💬
|
| 607 | Data collection FOR exploratory analyses OF endogenous steroid hormones | - | - | - | - | 1件: 41 41 💬
|
| 608 | Data collection FOR prednisone metabolism | - | - | - | - | 1件: 41 41 💬
|
| 609 | Dead SEA solar and water treatment (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 46 46 💬
|
| 610 | Decortin (prednisona) 5 MG comprimidos | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 611 | Definity perflutren lipid microsphere ultrasound contrast | 1件: Perflutren Perflutren | 1件: Perflutren
Perflutren
💬
| - | - | 1件: 70 70 💬
|
| 612 | Delgocitinib (Corectim) | 1件: Delgocitinib Delgocitinib | 1件: Delgocitinib
Delgocitinib
(Corectim) 💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 50 50 💬
|
| 613 | Depot tetracosactide (Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN) | - | - | - | - | 1件: 83 83 💬
|
| 614 | Dexamethasone combined with romiplostim N01 | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
| 615 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | 1件: 63 63 💬
|
| 616 | Diary completion | - | - | - | - | 1件: 6 6 💬
|
| 617 | Diazoxide choline controlled-release tablet | 1件: Diazoxide Diazoxide | 2件: Diazoxide
Diazoxide
,
Diazoxide choline
💬
| 2件: ABCC8 ABCC8, KCNJ11 💬
| 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 💬
|
| 618 | Diet and water adjustment (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 67 67 💬
|
| 619 | Dietary counseling | - | - | - | - | 1件: 46 46 💬
|
| 620 | Dificlir 200 MG compresse rivestite CON film | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
| 621 | Dificlir 200 MG FILM-coated tablets | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
| 622 | Dihydroergotoxine mesylate (Co-Dergocrin) | 2件: Dihydroergotoxine Dihydroergotoxine, Ergoloid mesylate (co-dergocrine mesylate) | 2件: Ergoloid mesylates
Ergoloid mesylates
,
Dihydroergotoxine
(Co-Dergocrin) 💬
| 6件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 623 | Diosmin and hesperidin combination | 1件: Diosmin Diosmin | 1件: Diosmin
Diosmin
💬
| - | - | 1件: 46 46 💬
|
| 624 | Diuretics (plus antiarrhythmic drugs, I.E. amiodarone, IN case OF complex ventricular arrhythmias) plus egcg | - | - | - | - | 1件: 28 28 💬
|
| 625 | Dmso cocktail | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | 1件: 226 226 💬
|
| 626 | DMT continuation | - | - | - | - | 1件: 13 13 💬
|
| 627 | Doptelet 20 MG FILM-coated tablets | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
| 628 | Drug free, IS monotherapy and GC combined with IS | - | - | - | - | 1件: 300 300 💬
|
| 629 | DSP-3077 retinal sheet cohort 1 | - | - | - | - | 1件: 90 90 💬
|
| 630 | DSP-3077 retinal sheet cohort 2 | - | - | - | - | 1件: 90 90 💬
|
| 631 | DSP-3077 retinal sheet cohort 3 | - | - | - | - | 1件: 90 90 💬
|
| 632 | Duchenne muscular dystrophy group without corticosteroids therapy | - | - | - | - | 1件: 113 113 💬
|
| 633 | Dynamic contrast-enhanced magnetic resonance imaging | - | - | - | - | 1件: 13 13 💬
|
| 634 | E. coli nissle | - | - | - | - | 1件: 97 97 💬
|
| 635 | Echo and myocardial contrast echocardiography perfusion imaging | - | - | - | - | 1件: 58 58 💬
|
| 636 | Efgartigimod concentrate FOR solution FOR infusion 20 MG/ML | - | - | - | - | 1件: 11 11 💬
|
| 637 | Eltrombopag combining rituximab | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
| 638 | Enalapril and other angiotensin converting enzyme inhibitors | 1件: Enalapril Enalapril | 2件: Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 19 19 💬
|
| 639 | END-OF-life nursing education consortium-pediatric palliative care AS WEB based-training plus usual care | - | - | - | - | 2件: 113 113, 299 💬
|
| 640 | Endoprost - 0.05 MG/0.5 ML concentrato PER soluzione PER infusione 1 fiala | - | - | - | - | 1件: 51 51 💬
|
| 641 | Entacapone (Comtan, COMTAN) | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
(Comtan, COMTAN) 💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 642 | Entacapone 400MG oral dose (Comtan, COMTAN) | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
(Comtan, COMTAN) 💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 643 | Entacapone and carbidopa (Comtan, COMTAN) | 2件: Carbidopa Carbidopa, Entacapone | 2件: Carbidopa
Carbidopa
,
Entacapone
(Comtan, COMTAN) 💬
| 2件: COMT COMT, DDC 💬
| 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 644 | Entacapone INN (Comtan, COMTAN) | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
(Comtan, COMTAN) 💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 645 | Enteric coated mycophenolate sodium | - | - | - | - | 1件: 228 228 💬
|
| 646 | Enteric-coated mycophenolate sodium | - | - | - | - | 1件: 49 49 💬
|
| 647 | Ephedrine hydrochloride (Corphedra) | 1件: Ephedrine Ephedrine | 3件: Ephedrine
Ephedrine
,
Ephedrine hydrochloride
,
Ephedrine sulfate
(Corphedra) 💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬
|
| 648 | Epinephrine (CERTA DOSE EPINEPHRINE CONVENIENCE KIT, EPINEPHRINE CONVENIENCE KIT) | 1件: Epinephrine Epinephrine | 3件: Epinephrine
Epinephrine
(CERTA DOSE EPINEPHRINE CONVENIENCE KIT, EPINEPHRINE CONVENIENCE KIT),
Epinephrine hydrochloride
,
Epinephrine bitartrate
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬
|
| 649 | Escherichia coli | 1件: Escherichia coli Escherichia coli (Escherichia coli) | - | - | - | 1件: 53 53 💬
|
| 650 | Etanercept, methotrexate, prednisolone (Delta-cortef) | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 56 56 💬
|
| 651 | EV substance code: SUB188638 | - | - | - | - | 1件: 113 113 💬
|
| 652 | Evaluation OF body composition and metabolism | - | - | - | - | 1件: 3 3 💬
|
| 653 | Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN healthy controls | - | - | - | - | 1件: 13 13 💬
|
| 654 | Evista 60MG FILM-coated tablets | 1件: Raloxifene Raloxifene | 2件: Raloxifene hydrochloride
Raloxifene hydrochloride
,
Raloxifene
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 77 77 💬
|
| 655 | EX-vivo approach concerning 25 patients | - | - | - | - | 3件: 102 102, 121, 299 💬
|
| 656 | EX-VIVO-expanded autologous human keratinocytes containing epidermal stem cells transduced with A LAMB3-encoding retroviral vector | - | - | - | - | 1件: 36 36 💬
|
| 657 | Exercise followed cold water immersion | - | - | - | - | 1件: 46 46 💬
|
| 658 | Exercise IN water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 6 6 💬
|
| 659 | Exhaled breath collection | - | - | - | - | 1件: 299 299 💬
|
| 660 | Exosomes derived from human umbilical cord blood mesenchymal stem cells FOR nasal drop | - | - | - | - | 1件: 2 2 💬
|
| 661 | Exosomes derived from human umbilical cord mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
| 662 | Experimental glatiramer acetate (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 663 | Extension cohort | - | - | - | - | 1件: 60 60 💬
|
| 664 | Ezetimibe+simvastatin drug combination | 1件: Ezetimibe Ezetimibe | 1件: Ezetimibe
Ezetimibe
💬
| 1件: NPC1L1 NPC1L1 💬
| 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 49 49 💬
|
| 665 | Fabrazyme - 35 MG polvere PER concentrato PER soluzione PER infusione endovenosa 1 flaconcino | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 666 | Factor viii concentrate | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
| 667 | Factor xiii concentrate (human), pasteurized | 1件: Factor XIII (human) Factor XIII (human) (Factor XIII concentrate) | - | - | - | 1件: 288 288 💬
|
| 668 | FDL176 & FDL169 coadministration | - | - | - | - | 1件: 299 299 💬
|
| 669 | Fenofibrate combined with ursodeoxycholic acid | 2件: Fenofibrate Fenofibrate, Ursodeoxycholic acid | 2件: Fenofibrate
Fenofibrate
,
Ursodiol
💬
| 2件: NR1C1 NR1C1, NR1H4 💬
| 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 670 | Fenofibrate IN combination with ursodeoxycholic acid | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 671 | Ferinject or cosmofer | - | - | - | - | 1件: 86 86 💬
|
| 672 | Ferro E.V. (come carbossimaltoso ferrico) - ferinject | - | - | - | - | 1件: 97 97 💬
|
| 673 | Fibrinogen concentrate | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 14 14 💬
|
| 674 | Fibrinogen concentrate from human plasma | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 65 65 💬
|
| 675 | Fibrinogen plasma concentration, coagulation factor xiii activity | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 288 288 💬
|
| 676 | FILM-coated tablet | - | - | - | - | 2件: 96 96, 97 💬
|
| 677 | Fipamezole ODT cohort 2 | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 💬
|
| 678 | Firdapse - 10 MG - compresse - USO orale - blister(ALU/PVC/pvdc) 100 X 1 compresse | - | - | - | - | 2件: 3 3, 11 💬
|
| 679 | First-line cognitive assessment | - | - | - | - | 1件: 3 3 💬
|
| 680 | Fish OIL concentrate | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 💬
|
| 681 | Fixed dose combination ciprofloxacin/celecoxib | - | - | - | - | 1件: 2 2 💬
|
| 682 | Fludarabina accord - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 5 flaconcini IN vetro DA 2 ML | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 19 19 💬
|
| 683 | Fludarabina teva - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 1 flaconcino DI vetro DA 2 ML | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬
|
| 684 | Follow-UP study OF THE treated cohort | - | - | - | - | 1件: 193 193 💬
|
| 685 | Follow-UP study OF THE untreated cohort | - | - | - | - | 1件: 193 193 💬
|
| 686 | Formistin - 10 MG compresse rivestite CON film 20 compresse | - | - | - | - | 1件: 13 13 💬
|
| 687 | Fostamatinib 50 MG blue FILM-coated tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 688 | Fragment antibody targeting human TFR1 conjugated TO phosphorodiamidate morpholino oligomer | - | - | - | - | 1件: 113 113 💬
|
| 689 | Gadolinium contrast | 1件: Gadolinium Gadolinium | - | - | - | 1件: 34 34 💬
|
| 690 | Gadolinium-based contrast | 1件: Gadolinium Gadolinium | - | - | - | 1件: 13 13 💬
|
| 691 | Gazyvaro - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 1000MG/40ML - 1 flaconcino | - | - | - | - | 1件: 222 222 💬
|
| 692 | Gelatin (Asini corii collas) | 1件: Gelatin Gelatin | 2件: Gelatin
Gelatin
,
Donkey glue
(Asini corii collas) 💬
| - | - | 3件: 47 47, 62, 70 💬
|
| 693 | General corticotherapy | - | - | - | - | 1件: 35 35 💬
|
| 694 | Givinostat hydrochloride - cohort 2 | 1件: Givinostat Givinostat | 1件: Givinostat
Givinostat
💬
| 11件: HDAC10 HDAC10, HDAC11, HDAC1_2, HDAC1_2, HDAC3, HDAC4_5, HDAC4_5, HDAC6, HDAC7, HDAC8, HDAC9 💬
| 20件: ATP-dependent chromatin remodeling ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | 1件: 113 113 💬
|
| 695 | Glatiramer acetate (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 3件: 13 13, 96, 156 💬
|
| 696 | Glatiramer acetate (GA) 40 MG (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 697 | Glatiramer acetate 150MG enteric coated tablets | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 698 | Glatiramer acetate 150MG enteric-coated (gastro-resistant) tablets | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 699 | Glatiramer acetate 20 MG (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 700 | Glatiramer acetate 20 MG, with mitoxantrone (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 701 | Glatiramer acetate 20 MG/0.5 ML (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 702 | Glatiramer acetate 40 MG (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 703 | Glatiramer acetate injection with oral cetirizine hydrochloride (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 704 | Glatiramer acetate with minocycline (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 705 | Glatiramer acetate, IFN-beta 1A (IM), IFN-beta 1A (subcutaneous), and IFN-beta 1B (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 706 | Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 707 | Glatiramer acetate, N-acetylcysteine (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 708 | Glatiramer acetato (Copaxone, COPAXONE) | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 709 | Glivec 100 MG comprimidos recubiertos CON PELícula | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 2件: 34 34, 86 💬
|
| 710 | Glivec 400 MG comprimidos recubiertos CON PELícula | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 34 34 💬
|
| 711 | Global DNA methylation will BE quantified IN THE DNA samples BY colorimetry | - | - | - | - | 1件: 63 63 💬
|
| 712 | GLPG3970 FILM-coated tablet | - | - | - | - | 1件: 49 49 💬
|
| 713 | Glucocorticoid combined with cyclophosphamide induction + maintenance | - | - | - | - | 1件: 222 222 💬
|
| 714 | GMP compliant-BM-MSC derived sevs | - | - | - | - | 1件: 90 90 💬
|
| 715 | Granulocyte colony stimulating factor | - | - | - | - | 6件: 2 2, 28, 36, 57, 65, 85 💬
|
| 716 | Granulocyte colony-stimulating factor | - | - | - | - | 2件: 60 60, 296 💬
|
| 717 | Granulocyte-colony stimulating factor (G-CSF) and prednisone | - | - | - | - | 1件: 13 13 💬
|
| 718 | Group 1- control diet | - | - | - | - | 1件: 97 97 💬
|
| 719 | Group C meningococcal conjugate vaccine | - | - | - | - | 1件: 14 14 💬
|
| 720 | Group exercise: community setting | - | - | - | - | 1件: 70 70 💬
|
| 721 | GSK1265744B (sodium salt) containing 14C-GSK1265744B | - | - | - | - | 1件: 265 265 💬
|
| 722 | H02 - corticosteroidi sistemici | - | - | - | - | 1件: 299 299 💬
|
| 723 | Haplo/cord transplant | - | - | - | - | 1件: 60 60 💬
|
| 724 | HarkáNY medicinal water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 46 46 💬
|
| 725 | HCQ/CQ and CAB combined treatment | - | - | - | - | 1件: 74 74 💬
|
| 726 | Healthy AGE-matched controls | - | - | - | - | 1件: 6 6 💬
|
| 727 | Healthy controls | - | - | - | - | 1件: 63 63 💬
|
| 728 | High dose vehicle control | - | - | - | - | 1件: 46 46 💬
|
| 729 | High resolution computed tomography (hrct) scans OF THE chest | - | - | - | - | 1件: 85 85 💬
|
| 730 | High water intake (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 67 67 💬
|
| 731 | HIGH-intensity training IN shallow and deep water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 6 6 💬
|
| 732 | HIGH-resolution optical coherence tomography | - | - | - | - | 1件: 41 41 💬
|
| 733 | Histamine (POSITIVE SKIN TEST CONTROL - HISTAMINE) | 1件: Histamine Histamine | 3件: Histamine dihydrochloride
Histamine dihydrochloride
(POSITIVE SKIN TEST CONTROL - HISTAMINE),
Histamine phosphate
,
Histamine
💬
| 4件: HRH1 HRH1, HRH2, HRH3, HRH4 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 734 | Historical control | - | - | - | - | 1件: 2 2 💬
|
| 735 | HMG coenzyme reductase | - | - | - | - | 1件: 79 79 💬
|
| 736 | Human coagulation factor viii | 2件: Antihemophilic factor human Antihemophilic factor human (Human coagulation factor VIII), Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
| 737 | Human coagulation factor viii / VON willebrand factor | 2件: Antihemophilic factor human Antihemophilic factor human (Human coagulation factor VIII), Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 738 | Human coagulation factor viii, VON willebrand factor | 2件: Antihemophilic factor human Antihemophilic factor human (Human coagulation factor VIII), Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 739 | Human coagulation factor viii, VON willebrand factor complex | 2件: Antihemophilic factor human Antihemophilic factor human (Human coagulation factor VIII), Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 740 | Human coagulation factor viii, VON willebrand human coagulation factor | 1件: Antihemophilic factor human Antihemophilic factor human (Human coagulation factor VIII) | - | - | - | 1件: 288 288 💬
|
| 741 | Human coagulation factor X | 1件: Coagulation factor X human Coagulation factor X human (Human coagulation factor X) | - | - | - | 1件: 288 288 💬
|
| 742 | Human fibrinogen concentrate | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 65 65 💬
|
| 743 | Human interferon BETA-1A and glatiramer acetate (Copaxone, COPAXONE) | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 744 | Human monoclonal antibody directed against complement 5 protein | - | - | - | - | 1件: 62 62 💬
|
| 745 | Human umbilical cord blood-derived mesenchymal stem cells | - | - | - | - | 1件: 36 36 💬
|
| 746 | Human umbilical cord derived MSC transplantation FOR SLE | - | - | - | - | 1件: 49 49 💬
|
| 747 | Human umbilical cord mesenchymal stem cell injection | - | - | - | - | 1件: 85 85 💬
|
| 748 | Human umbilical cord mesenchymal stem cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Human Umbilical Cord Wharton’s Jelly-derived Mesenchymal Stem Cells) | - | - | - | 4件: 13 13, 96, 113, 271 💬
|
| 749 | Human umbilical CORD-derived mscs | - | - | - | - | 1件: 271 271 💬
|
| 750 | Human umbilical CORD-derived mscs and cyclosporin A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬
|
| 751 | Human VWF/fviii concentrate | - | - | - | - | 1件: 288 288 💬
|
| 752 | Humanised VHH-type bispecific antibody against complement component 5 and serum albumin | - | - | - | - | 1件: 11 11 💬
|
| 753 | Hydrocortisone (Colocort, Cortef, CORTEF, CORTENEMA) | 2件: Hydrocortisone Hydrocortisone (Cortisol), Hydrocortisone acetate (Cortisol 21-acetate) | 2件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA),
Hydrocortisone acetate
(Cortifoam, U-cort, CORTIFOAM) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 8件: 41 41, 53, 75, 78, 81, 83, 97, 299 💬
|
| 754 | Hydrocortisone - hydrocortisone tablet (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 755 | Hydrocortisone 100MG/ML (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬
|
| 756 | Hydrocortisone 10MG (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 757 | Hydrocortisone 10MG tablet (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 758 | Hydrocortisone 10MG tablets (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 759 | Hydrocortisone 20MG tablets (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 760 | Hydrocortisone cream (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 761 | Hydrocortisone cream 10MG/G FNA fagron (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 762 | Hydrocortisone hydrogen succinate (Colocort, Cortef, CORTEF, CORTENEMA) | 2件: Hydrocortisone Hydrocortisone (Cortisol), Hydrocortisone succinate (Cortisol 21-) | 3件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA),
Hydrocortisone sodium succinate
(Solu-cortef, SOLU-CORTEF),
Hydrocortisone succinate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬
|
| 763 | Hydrocortisone micronized (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 764 | Hydrocortisone modified release capsules (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 765 | Hydrocortisone roussel (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬
|
| 766 | Hydrocortisone sodium acetate (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 767 | Hydrocortisone sodium phosphate (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 53 53, 81, 83 💬
|
| 768 | Hydrocortisone sodium succinate (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 81 81, 83 💬
|
| 769 | Hydrocortisone tablet 2.5 MG (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 770 | Hydrocortisone takeda, tabletter (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 💬
|
| 771 | Hydrocortisone withdrawal (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 772 | Hydrocortisone- hydrocortisone tablet (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 773 | Hyperbaric oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 2件: 96 96, 97 💬
|
| 774 | Hyperbaric oxygen therapy (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 97 97 💬
|
| 775 | Hyperglycemic clamp with concurrent GIP infusion | - | - | - | - | 1件: 299 299 💬
|
| 776 | Hyperglycemic clamp with concurrent GLP-1 infusion | - | - | - | - | 1件: 299 299 💬
|
| 777 | Hyperpolarized 129 xenon GAS comparing idiopathic pulmonary fibrosis (IPF) treatment | - | - | - | - | 1件: 85 85 💬
|
| 778 | Hyperpolarized 129 xenon GAS comparing progressive pulmonary fibrosis treatment | - | - | - | - | 1件: 85 85 💬
|
| 779 | Ibuprofen and isosorbide dinitrate combination | 1件: Ibuprofen Ibuprofen | 5件: Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 113 113 💬
|
| 780 | IC cocktail | - | - | - | - | 1件: 226 226 💬
|
| 781 | Idebenone 150 MG FILM-coated tablets | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 1件: 113 113 💬
|
| 782 | Identification OF comt HH, comt HL or comt LL genes | - | - | - | - | 1件: 6 6 💬
|
| 783 | Immediate treatment with corticosteroids | - | - | - | - | 1件: 11 11 💬
|
| 784 | Immunoglobulin G cleaving cystein protease derived from E. coli | - | - | - | - | 2件: 43 43, 44 💬
|
| 785 | Immunoglobulina DI coniglio antitimociti umani | - | - | - | - | 1件: 51 51 💬
|
| 786 | Immunosuppression only conditioning | - | - | - | - | 1件: 65 65 💬
|
| 787 | Immunosuppression only conditioning -closed with amendment L | - | - | - | - | 1件: 65 65 💬
|
| 788 | IN vitro stimulation OF blood with periodontitis-associated- and control bacteria | - | - | - | - | 1件: 46 46 💬
|
| 789 | IN-vitro approach concerning 25 patients | - | - | - | - | 3件: 102 102, 121, 299 💬
|
| 790 | Inalossin - 800 PPM MOL/MOL GAS medicinale compresso bombola IN alluminio CON valvola VI DA 20 litri | - | - | - | - | 1件: 294 294 💬
|
| 791 | Inalossin 800 PPM MOL/MOL GAS medicinale compresso | - | - | - | - | 1件: 294 294 💬
|
| 792 | Increased dietary intake OF salmon or COD | - | - | - | - | 1件: 97 97 💬
|
| 793 | Inflectra - 100 MG - polvere PER concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 1 flaconcino | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 56 56 💬
|
| 794 | Inflectra 100 MG powder FOR concentrate FOR solution FOR infusion | - | - | - | - | 2件: 96 96, 97 💬
|
| 795 | Infliximab and azathioprine combination AT week 0 | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 796 | Infliximab and azathioprine combination AT week 14 | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 797 | Infliximab control | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 798 | Information collected AS standard OF care | - | - | - | - | 1件: 46 46 💬
|
| 799 | Inhibace/cozaar | - | - | - | - | 1件: 66 66 💬
|
| 800 | Inhibidor DE LA esterasa C1 complemento | - | - | - | - | 1件: 65 65 💬
|
| 801 | Injection OF umbilical cord derived mscs | - | - | - | - | 1件: 6 6 💬
|
| 802 | INN colecalciferol | - | - | - | - | 1件: 13 13 💬
|
| 803 | Intelence - 200 MG - compressa -USO orale - flacone (hdpe) 60 compresse | 1件: Etravirine Etravirine | 1件: Etravirine
Etravirine
💬
| - | - | 1件: 18 18 💬
|
| 804 | Interferon or glatiramer acetate (Copaxone, COPAXONE) | - | - | - | - | 1件: 13 13 💬
|
| 805 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab (Copaxone, COPAXONE) | - | - | - | - | 1件: 13 13 💬
|
| 806 | Intervention FOR madopar + entacapone group (Comtan, COMTAN) | - | - | - | - | 1件: 6 6 💬
|
| 807 | Intra-articular compound betamethasone | - | - | - | - | 1件: 46 46 💬
|
| 808 | Intra-articular corticosteroid injection | - | - | - | - | 1件: 46 46 💬
|
| 809 | Intraarticular morphine (MS contin, MS CONTIN) | - | - | - | - | 1件: 46 46 💬
|
| 810 | Intravenous methyl prednisolone (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 43 43 💬
|
| 811 | Iron (III) hydroxide hydroxyethyl starch glucopheptonic acid complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
| 812 | Iron HES complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
| 813 | Iron isomalto-oligosaccharide complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
| 814 | Iron isomaltoside complex - iron isomaltoside 1000 | 2件: Iron Iron, Iron isomaltoside 1000 | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
| 815 | Iron oligosaccharide complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
| 816 | Iron sulphate 200MG coated tablets | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
| 817 | Iron(III)- hydroxide dextran complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
| 818 | Iron(III)-hydroxide dextran complex | - | - | - | - | 1件: 97 97 💬
|
| 819 | IV corticosteroid | - | - | - | - | 1件: 97 97 💬
|
| 820 | IV steroids combination alone | - | - | - | - | 1件: 41 41 💬
|
| 821 | Jinarc - 15 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 822 | Jinarc - 30 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 823 | JNJ-38518168-ZBQ - FILM-coated tablet - 10 MG | - | - | - | - | 1件: 46 46 💬
|
| 824 | JNJ-38518168-ZBQ - FILM-coated tablet - 10MG | - | - | - | - | 1件: 46 46 💬
|
| 825 | JNJ-38518168-ZBQ - FILM-coated tablet - 3 MG | - | - | - | - | 1件: 46 46 💬
|
| 826 | JNJ-38518168-ZBQ - FILM-coated tablet - 30 MG | - | - | - | - | 1件: 46 46 💬
|
| 827 | JNJ-38518168-ZBQ - FILM-coated tablet - 30MG | - | - | - | - | 1件: 46 46 💬
|
| 828 | JNJ-38518168-ZBQ - FILM-coated tablet - 3MG | - | - | - | - | 1件: 46 46 💬
|
| 829 | JNJ-39758979-AAC - enteric coated tablet - 10 MG | 1件: JNJ-39758979 JNJ-39758979 | - | - | - | 1件: 46 46 💬
|
| 830 | JNJ-39758979-AAC - enteric coated tablet - 100 MG | 1件: JNJ-39758979 JNJ-39758979 | - | - | - | 1件: 46 46 💬
|
| 831 | JNJ-39758979-AAC - enteric coated tablet - 30 MG | 1件: JNJ-39758979 JNJ-39758979 | - | - | - | 1件: 46 46 💬
|
| 832 | Jorveza 0.5 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 833 | Jorveza 1 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 834 | Jyseleca 100 MG FILM-coated tablets | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 835 | Jyseleca 100MG FILM-coated tablets | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 836 | Jyseleca 200 MG FILM-coated tablets | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 837 | Kalydeco 150 MG FILM-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 838 | KVD824 300 MG compresse A rilascio modificato | - | - | - | - | 1件: 65 65 💬
|
| 839 | KVD900 100 MG film coated tablet | - | - | - | - | 1件: 65 65 💬
|
| 840 | KVD900 300 MG compressa rivestita CON film | - | - | - | - | 1件: 65 65 💬
|
| 841 | KVD900 300 MG film coated tablet | - | - | - | - | 1件: 65 65 💬
|
| 842 | L01X CO2 | - | - | - | - | 1件: 46 46 💬
|
| 843 | L04aa04 - immunoglobulina antitimocitaria (DI coniglio) immunoglobulina DI coniglio antitimociti umani thymoglobuline | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 1件: 13 13 💬
|
| 844 | Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 1件: 6 6 💬
|
| 845 | Lactose IN water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Lactose Lactose | 2件: Anhydrous lactose
Anhydrous lactose
,
Lactose
💬
| - | - | 1件: 97 97 💬
|
| 846 | Large dose OF prednisolone plus intra-lesional OF triamcinolone acetonide followed THE systemic combination OF mycophenolate mofetil (MMF), dapsone and LOW dose prednisolone IN treatment OF MMP | - | - | - | - | 1件: 162 162 💬
|
| 847 | Ledertrexato 2,5 MG compriméS | - | - | - | - | 1件: 46 46 💬
|
| 848 | Lentiviral vector containing ABCA4 gene | - | - | - | - | 1件: 301 301 💬
|
| 849 | Lentiviral vector containing MYO7A gene | - | - | - | - | 2件: 90 90, 303 💬
|
| 850 | Lentiviral vector containing THE ABCA4 gene | - | - | - | - | 1件: 301 301 💬
|
| 851 | Lentiviral vector containing THE human MY07A gene | - | - | - | - | 2件: 90 90, 303 💬
|
| 852 | Leukapheresis- collection OF stem cells | - | - | - | - | 1件: 96 96 💬
|
| 853 | Levodopa, carbidopa, entacapone (Comtan, COMTAN) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 854 | Levodopa, decarboxylase inhibitor and comt inhibitor | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 855 | Levodopa-carbidopa-entacapone (Comtan, COMTAN) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan, COMTAN) 💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 856 | Levodopa/carbidopa/entacapone (Comtan, COMTAN) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan, COMTAN) 💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 857 | Lidocaine 2% without vessel constrictor | 1件: Lidocaine Lidocaine | 3件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 51 51 💬
|
| 858 | Linaclotide (Constella) | 1件: Linaclotide Linaclotide | 2件: Linaclotide acetate
Linaclotide acetate
,
Linaclotide
(Constella) 💬
| 1件: GUCY2C GUCY2C 💬
| 2件: Hormone signaling Hormone signaling, Purine metabolism 💬 | 2件: 6 6, 97 💬
|
| 859 | Lisinopril, losartan, and atorvastatin (Cozaar, COZAAR) | 1件: Lisinopril Lisinopril | 2件: Lisinopril
Lisinopril
,
Lisinopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 222 222 💬
|
| 860 | Live combined bacillus subtilis and enterococcus faecium enteric-coated capsules combined with bortezomib+dexamethasone/bortezomib+dexamethasone+daratumumab/single daratumumab | 3件: Bortezomib Bortezomib, Daratumumab, Dexamethasone | 5件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Bortezomib
,
Dexamethasone phosphate
,
Daratumumab
💬
| 3件: CD38 CD38, NR3C1, PSMB5 💬
| 15件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
| 861 | Live combined bifidobacterium,lactobacillus and enterococcus capsules | - | - | - | - | 1件: 6 6 💬
|
| 862 | LO-ovral oral contraceptive pills | - | - | - | - | 1件: 60 60 💬
|
| 863 | Long term oxygen therapy (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 88 88 💬
|
| 864 | LONG-circulating liposomal prednisolone (Delta-cortef) | - | - | - | - | 1件: 46 46 💬
|
| 865 | Losartan (Cozaar, COZAAR) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 15件: 17 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
|
| 866 | Losartan and nebivolol (Cozaar, COZAAR) | 2件: Losartan Losartan, Nebivolol | 4件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Nebivolol
,
Nebivolol hydrochloride
,
Losartan
💬
| 2件: ADRB1 ADRB1, AGTR1 💬
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
| 867 | Losartan and other angiotensin receptor blockers (Cozaar, COZAAR) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 19 19 💬
|
| 868 | Losartan bluefish 50 MG (Cozaar, COZAAR) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 869 | Losartan hexal (Cozaar, COZAAR) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 36 36 💬
|
| 870 | Losartan potasico (Cozaar, COZAAR) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 179 179 💬
|
| 871 | Losartan potassium (Cozaar, COZAAR) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 36 36, 98, 167, 179, 215 💬
|
| 872 | Losartan tablets & qingremoshen granule (Cozaar, COZAAR) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
| 873 | LOW antigen content diet | - | - | - | - | 1件: 66 66 💬
|
| 874 | LOW blood pressure control | - | - | - | - | 1件: 67 67 💬
|
| 875 | LOW copper diet | - | - | - | - | 1件: 171 171 💬
|
| 876 | LOW dose prednisolone (Delta-cortef) | - | - | - | - | 1件: 84 84 💬
|
| 877 | LOW dose vehicle control | - | - | - | - | 1件: 46 46 💬
|
| 878 | LOW-FAT control diet | - | - | - | - | 1件: 124 124 💬
|
| 879 | LUM/IVA fixed-dose combination | - | - | - | - | 1件: 299 299 💬
|
| 880 | Lumacaftor plus ivacaftor combination | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 881 | Lumacaftor, ivacaftor drug combination | 1件: Lumacaftor Lumacaftor | 1件: Lumacaftor
Lumacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 882 | Lumason® contrast agent | - | - | - | - | 1件: 21 21 💬
|
| 883 | Luspatercept combine with deferasirox | 1件: Luspatercept Luspatercept | 1件: Luspatercept
Luspatercept
💬
| 1件: ACVR2B ACVR2B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 60 60 💬
|
| 884 | Lyophilized concentrate OF human coagulation VON willebrand factor and factor viii | - | - | - | - | 1件: 288 288 💬
|
| 885 | Lzrse-COL7a1 engineered autologous epidermal sheets | - | - | - | - | 1件: 36 36 💬
|
| 886 | Mabcampath 10 MG/ML concentrado para solucióN para perfusióN | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 887 | Mabthera 100 MG concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 888 | Mabthera 500 MG (10 MG/ML) concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 889 | Mabthera 500 MG concentrado para solucióN para perfusióN | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 890 | Mabthera 500 MG concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 222 💬
|
| 891 | Mabthera®, 100 MG concentrado para solucióN para perfusióN | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 892 | Mabthera®, 100 MG concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 893 | Macitentan compresse | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 88 💬
|
| 894 | Magnesium sulfate (Conclyte-Mg) | 2件: Magnesium Magnesium, Magnesium sulfate | 1件: Magnesium sulfate
Magnesium sulfate
(Conclyte-Mg) 💬
| - | - | 3件: 11 11, 296, 297 💬
|
| 895 | Magnesium sulfate heptahydrate (Conclyte-Mg) | 2件: Magnesium Magnesium, Magnesium sulfate | 1件: Magnesium sulfate
Magnesium sulfate
(Conclyte-Mg) 💬
| - | - | 1件: 97 97 💬
|
| 896 | Management OF therapy complications | - | - | - | - | 2件: 28 28, 60 💬
|
| 897 | Marketed plasma-derived VWF/fviii concentrate | - | - | - | - | 1件: 288 288 💬
|
| 898 | Mavenclad - 10 MG - compressa - USO orale - blister (AL/AL) - 6 compresse | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 899 | Mayzent 0,25 MG compresse rivestite CON film | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 900 | Mayzent 2 MG compresse rivestite CON film | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 901 | Mayzent 2 MG FILM-coated tablets | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 902 | Measure OF arginine-stimulated copeptin | - | - | - | - | 2件: 72 72, 225 💬
|
| 903 | Measure OF basal copeptin level | - | - | - | - | 2件: 72 72, 225 💬
|
| 904 | Medical AIR (AIR COMPRESSED) | 1件: Medical air Medical air | 1件: Air, medical
Air, medical
(AIR COMPRESSED) 💬
| - | - | 2件: 85 85, 86 💬
|
| 905 | Medical AIR VS oxygen (AIR COMPRESSED) | 1件: Medical air Medical air | 1件: Air, medical
Air, medical
(AIR COMPRESSED) 💬
| - | - | 1件: 193 193 💬
|
| 906 | Medical grade oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 299 299 💬
|
| 907 | Medication compliance phone call | - | - | - | - | 1件: 98 98 💬
|
| 908 | Medium dose prednisolone (Delta-cortef) | - | - | - | - | 1件: 84 84 💬
|
| 909 | Medrol - 4 MG compresse 30 compresse | - | - | - | - | 1件: 56 56 💬
|
| 910 | Meningococcal group A oligosaccharides conjugated TO corynebacterium diphtheriae C7 (ß197) M8 (CRM197) protein | - | - | - | - | 1件: 11 11 💬
|
| 911 | Meningococcal group W oligosaccharides conjugated TO corynebacterium diphtheriae C7 (ß197) M8 (CRM197) protein | - | - | - | - | 1件: 11 11 💬
|
| 912 | Meningococcal group Y oligosaccharides conjugated TO corynebacterium diphtheriae C7 (Â197) M8 (CRM197) protein | - | - | - | - | 1件: 11 11 💬
|
| 913 | Menveo - polv.E soluz.PER soluz. iniett.-USO intramuscolare-comp. coniug.liofilizz.mena:flac.(vetro) comp. goniug.liqui.mencwy:flac.(vetro)-1 flac+1flac | - | - | - | - | 2件: 62 62, 66 💬
|
| 914 | Mesalazine with hydrocortisone sodium succinate (Colocort, Cortef, CORTEF, CORTENEMA) | 2件: Hydrocortisone Hydrocortisone (Cortisol), Mesalazine | 2件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA),
Mesalamine
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 915 | Metformin and clemastine IN combination | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 916 | Metformina - 500 30 compresse 500 MG | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
| 917 | Methotrexate - etanercept - prednisolone ARM (Delta-cortef) | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 918 | Methotrexate combined with tofacitinib | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 919 | Methyl prednisolone (Delta-cortef) | - | - | - | - | 2件: 49 49, 96 💬
|
| 920 | Methylcellulose (Cologel) | 1件: Methylcellulose Methylcellulose | 1件: Methylcellulose
Methylcellulose
(Cologel) 💬
| - | - | 1件: 36 36 💬
|
| 921 | Methylphenidate (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 34, 84, 113 💬
|
| 922 | Methylphenidate 10MG tablets (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 84 84 💬
|
| 923 | Methylphenidate hydrochloride (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 💬
|
| 924 | Methylphenidate modified release (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 925 | Methylphenidate modified release 20 MG (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 926 | Methylphenidate modified release 30 MG (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 927 | Methylphenidate modified release 40 MG (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 928 | Methylphenidate oral solution (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 206 206 💬
|
| 929 | Methylphenidate, fluoxetin, risperidone (Concerta, CONCERTA, COTEMPLA XR-ODT) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Concerta, CONCERTA, COTEMPLA XR-ODT),
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 179 179, 206 💬
|
| 930 | Metoclopramide accord - 10 MG compresse 28 compresse IN blister PVC/pvdc/AL | 1件: Metoclopramide Metoclopramide | 3件: Metoclopramide
Metoclopramide
,
Metoclopramide hydrochloride
,
Metoclopramide hydrochloride
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 51 51 💬
|
| 931 | Metopirone 250 MG capsules/ cormeto | 1件: Metyrapone Metyrapone | 1件: Metyrapone
Metyrapone
💬
| 1件: CYP11B1 CYP11B1 💬
| 3件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|
| 932 | Metopirone 250 MG capsules/cormeto | 1件: Metyrapone Metyrapone | 1件: Metyrapone
Metyrapone
💬
| 1件: CYP11B1 CYP11B1 💬
| 3件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|
| 933 | Metotrexato-lederle 2,5 MG comprimidos | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 934 | Minibody against CD8 conjugated TO desferrioxamine labeled with zirconium ZR 89 | - | - | - | - | 1件: 51 51 💬
|
| 935 | Minocycline 100 MG FILM-coated tablets | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 1件: 13 13 💬
|
| 936 | Mobility study IN DRY conditions | - | - | - | - | 1件: 3 3 💬
|
| 937 | Mobility study IN water conditions | - | - | - | - | 1件: 3 3 💬
|
| 938 | Moderna covid-19 vaccine | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine (MRNA-1273 SARS-COV-2) | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine, Covid-19 vaccine, Moderna Covid-19 vaccine) 💬
| - | - | 1件: 46 46 💬
|
| 939 | Modified cobratoxin | - | - | - | - | 1件: 20 20 💬
|
| 940 | Modified mrna encoding human methylmalonyl-coenzyme A mutase | - | - | - | - | 1件: 246 246 💬
|
| 941 | Modified zhiwang decoction combined with methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 942 | Monores 20 MCG 30 compresse | - | - | - | - | 1件: 1 1 💬
|
| 943 | Monovalent [B.1.351] COV2 pres DTM-AS03 | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 944 | Morphine (MS contin, MS CONTIN) | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
(MS contin, MS CONTIN),
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 298 💬
|
| 945 | Morphine hexal (MS contin, MS CONTIN) | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
(MS contin, MS CONTIN),
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 946 | Morphine hydrochloride (MS contin, MS CONTIN) | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
(MS contin, MS CONTIN),
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 💬
|
| 947 | Morphine PCA (MS contin, MS CONTIN) | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
(MS contin, MS CONTIN),
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 💬
|
| 948 | Morphine sulfate (MS contin, MS CONTIN) | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
(MS contin, MS CONTIN),
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 85, 86 💬
|
| 949 | Morphine sulphate IN intrasite GEL (MS contin, MS CONTIN) | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
(MS contin, MS CONTIN),
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 36 36 💬
|
| 950 | Motor imagery AS compared TO physical practice FOR balance tasks | - | - | - | - | 1件: 13 13 💬
|
| 951 | MRI contrast-enhancing agents | - | - | - | - | 1件: 13 13 💬
|
| 952 | MRI contrast-enhancing preparations | - | - | - | - | 1件: 13 13 💬
|
| 953 | MRI with contrast agent injection | - | - | - | - | 1件: 19 19 💬
|
| 954 | MRI without contrast agent injection | - | - | - | - | 1件: 19 19 💬
|
| 955 | Mrna CHE codifica L’enzima umano deramificante DEL glicogeno formulato IN UNA nanopaticella lipidica | - | - | - | - | 1件: 257 257 💬
|
| 956 | Mrna codificante PER ornitina transcarbamilasi modificata | - | - | - | - | 1件: 251 251 💬
|
| 957 | Mrna COVD19 vaccine | - | - | - | - | 4件: 49 49, 53, 97, 271 💬
|
| 958 | Mrna covid-19 vaccine | - | - | - | - | 1件: 13 13 💬
|
| 959 | Myeloablative conditioning regimen | - | - | - | - | 1件: 164 164 💬
|
| 960 | Myeloablative conditioning-closed with amendment L | - | - | - | - | 1件: 65 65 💬
|
| 961 | Myozyme 50 MG powder FOR concentrate FOR solution FOR infusion | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
| 962 | N. meningitidis group C (strain C11) oligosaccharide conjugated TO corynebacterium diphtheriae CRM197 adsorbed ON aluminum hydroxide | - | - | - | - | 1件: 11 11 💬
|
| 963 | N. meningitidis group W135 oligosaccharide conjugated CRM197 | - | - | - | - | 1件: 13 13 💬
|
| 964 | Nadolol (Corgard) | 1件: Nadolol Nadolol | 1件: Nadolol
Nadolol
(Corgard) 💬
| 2件: ADRB1 ADRB1, ADRB2 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 965 | Natural herbs OF coconut, aloe vera, and pepperint | - | - | - | - | 1件: 53 53 💬
|
| 966 | Nebulized combination ipratropium bromide with salbutamol | - | - | - | - | 1件: 86 86 💬
|
| 967 | Neisseria meningitidis group A polysaccharide conjugated with tetanus toxoid carrier protein | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | 2件: Tetanus toxoid adsorbed
Tetanus toxoid adsorbed
,
Tetanus toxoid
💬
| - | - | 1件: 50 50 💬
|
| 968 | Neisseria meningitidis group W-135 polysaccharide conjugated TO teta | - | - | - | - | 1件: 50 50 💬
|
| 969 | Neisseria meningitidis group W-135 polysaccharide conjugated TO tetanus toxoid carrier protein | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | 2件: Tetanus toxoid adsorbed
Tetanus toxoid adsorbed
,
Tetanus toxoid
💬
| - | - | 1件: 50 50 💬
|
| 970 | Nerixia*infus IV conc 2F 100MG | - | - | - | - | 1件: 274 274 💬
|
| 971 | Nicotine and cotinine serum levels | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 13 13 💬
|
| 972 | Nitisinone 10 MG tablet high compritol | 1件: Nitisinone Nitisinone | 1件: Nitisinone
Nitisinone
💬
| 1件: HPD HPD 💬
| 3件: Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 241 241 💬
|
| 973 | Nitric oxide plus oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 2件: Nitric Oxide Nitric Oxide, Oxygen | 2件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.),
Nitric oxide
💬
| - | - | 1件: 86 86 💬
|
| 974 | Nocturnal oxygen , nocturnal BI-level positive pressure ventilation (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 299 299 💬
|
| 975 | NON ATG conditioning regimen | - | - | - | - | 1件: 60 60 💬
|
| 976 | NON commercial | - | - | - | - | 1件: 75 75 💬
|
| 977 | NON-enteric coated pancreatic enzyme preparation | - | - | - | - | 1件: 298 298 💬
|
| 978 | Normal (control) diet | - | - | - | - | 1件: 240 240 💬
|
| 979 | Norvir 100 MG FILM-coated tablets | - | - | - | - | 1件: 299 299 💬
|
| 980 | Novartis pharmaceuticals corporation | - | - | - | - | 1件: 13 13 💬
|
| 981 | Nutraceutical combination | - | - | - | - | 1件: 96 96 💬
|
| 982 | Nutrition counseling | - | - | - | - | 1件: 298 298 💬
|
| 983 | Nutritional formulation containing exogenous ketones | - | - | - | - | 1件: 201 201 💬
|
| 984 | O-15 water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 6 6 💬
|
| 985 | Observational cohort | - | - | - | - | 1件: 6 6 💬
|
| 986 | Observational control | - | - | - | - | 1件: 13 13 💬
|
| 987 | OFF-label compassionate drug USE | - | - | - | - | 1件: 21 21 💬
|
| 988 | Olumiant® 2 MG compriméS PélliculéS | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 50 50 💬
|
| 989 | Ondansetron 8 MG FILM-coated tablets | 1件: Ondansetron Ondansetron | 2件: Ondansetron
Ondansetron
,
Ondansetron hydrochloride hydrate
💬
| 5件: HTR3 HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 💬
|
| 990 | ONE ML contains horse ANTI-human T lymphocyte immunoglobulin (eatg) 50 MG | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | 1件: Anti-human thymocyte immunoglobulin, equine
Anti-human thymocyte immunoglobulin, equine
💬
| - | - | 1件: 60 60 💬
|
| 991 | Optical coherence tomography angiography | - | - | - | - | 1件: 41 41 💬
|
| 992 | Optional blood-oxygen-level dependent functionalmri (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 6 6 💬
|
| 993 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO methylprednisolone | - | - | - | - | 1件: 97 97 💬
|
| 994 | Oral bovine type I collagen | - | - | - | - | 1件: 51 51 💬
|
| 995 | Oral bovine type II collagen | - | - | - | - | 1件: 46 46 💬
|
| 996 | Oral contrast media application | - | - | - | - | 1件: 96 96 💬
|
| 997 | Oral corticosteroids | - | - | - | - | 4件: 13 13, 46, 97, 251 💬
|
| 998 | Oral prednisolone (Delta-cortef) | - | - | - | - | 3件: 49 49, 96, 145 💬
|
| 999 | Oral prednisolone and cyclophosphamide (Delta-cortef) | - | - | - | - | 1件: 222 222 💬
|
| 1000 | Oral prednisolone and SOC (Delta-cortef) | - | - | - | - | 1件: 66 66 💬
|
| 1001 | Orencia 250 MG polvo para concentrado para SOL. para perfusióN | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
| 1002 | Orencia 250MG powder FOR concentrate FOR solution FOR infusion | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
| 1003 | Orkambi 100 MG/125 MG FILM-coated tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1004 | Orkambi 200 MG/125 MG FILM-coated tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1005 | Orkambi: contains lumacaftor and ivacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1006 | Otezla - 10 MG + 20 MG + 30 MG compressa rivestita CON film USO orale - blister (PVC/ALU) IN UN astuccio - 4 compresse DA 10 MG + 4 compresse DA 20 MG +19 compresse DA 30 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬
|
| 1007 | Other COX-2 inhibitor | - | - | - | - | 1件: 271 271 💬
|
| 1008 | Other COX-2 inhibitors | - | - | - | - | 1件: 271 271 💬
|
| 1009 | Outer membrane vesicles (OMV) from neisseria meningitidis group B strain NZ98/254measured AS amount OF total protein containing THE pora P1.4 | - | - | - | - | 1件: 11 11 💬
|
| 1010 | Over THE counter DHA/EPA dietary supplementation | - | - | - | - | 1件: 301 301 💬
|
| 1011 | OVER-encapsulated entacapone tablets (Comtan, COMTAN) | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
(Comtan, COMTAN) 💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1012 | Overencapsulated prednisolone tablets (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1013 | Oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 13件: 22 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
|
| 1014 | Oxygen - AIR (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 299 299 💬
|
| 1015 | Oxygen administration (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 88 88 💬
|
| 1016 | Oxygen flow AT THE optic nerve head measurement (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 19 19 💬
|
| 1017 | Oxygen GAS FOR inhalation (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 2件: 96 96, 97 💬
|
| 1018 | Oxygen medicinal GAS SOL 100% V/V medicinal GAS, compressed | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 97 97 💬
|
| 1019 | Oxygen supplementation (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 86 86 💬
|
| 1020 | Oxygen, liquid (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 2件: 86 86, 88 💬
|
| 1021 | Oxygen, medical GAS (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 211 211 💬
|
| 1022 | Oxygen-15 water (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) 💬
| - | - | 1件: 6 6 💬
|
| 1023 | Oxytocin (OXT) continuous | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬
| 1件: OXTR OXTR 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 193 193 💬
|
| 1024 | P-MPA concentration | - | - | - | - | 1件: 51 51 💬
|
| 1025 | Pancrelipase (Cotazym) | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
(Cotazym) 💬
| - | - | 4件: 96 96, 97, 298, 299 💬
|
| 1026 | Pancrelipase amylase (Cotazym) | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
(Cotazym) 💬
| - | - | 1件: 299 299 💬
|
| 1027 | Pancrelipase delayed release (Cotazym) | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
(Cotazym) 💬
| - | - | 1件: 299 299 💬
|
| 1028 | Pancrelipase delayed release capsule (Cotazym) | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
(Cotazym) 💬
| - | - | 2件: 298 298, 299 💬
|
| 1029 | Pancrelipase microtablets (Cotazym) | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
(Cotazym) 💬
| - | - | 1件: 299 299 💬
|
| 1030 | Pancrelipase with bicarbonate (Cotazym) | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
(Cotazym) 💬
| - | - | 1件: 299 299 💬
|
| 1031 | Pancrelipase/pancreas powder (Cotazym) | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
(Cotazym) 💬
| - | - | 2件: 298 298, 299 💬
|
| 1032 | Paracetamolo DOC generici - 1000 MG compressa 16 compresse | - | - | - | - | 1件: 19 19 💬
|
| 1033 | Paracetamolo nova argentia - 500 MG compresse 20 compresse | - | - | - | - | 1件: 300 300 💬
|
| 1034 | Paroxetine & prednisolone (Delta-cortef) | 2件: Paroxetine Paroxetine, Prednisolone | 5件: Prednisolone
Prednisolone
(Delta-cortef),
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| 2件: NR3C1 NR3C1, SLC6A4 💬
| 4件: Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
| 1035 | Paroxetine hydrochloride 10 & 20 MG and prednisolone 1 MG BP (Delta-cortef) | 1件: Paroxetine Paroxetine | 4件: Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
| 1036 | Paroxetine hydrochloride tablets 10 & 20 MG and prednisolone 1 MG BP (Delta-cortef) | 1件: Paroxetine Paroxetine | 4件: Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
| 1037 | Part 1, JM-010 component group A | - | - | - | - | 1件: 6 6 💬
|
| 1038 | Part 1, JM-010 component group B | - | - | - | - | 1件: 6 6 💬
|
| 1039 | Part 1, JM-010 component group C | - | - | - | - | 1件: 6 6 💬
|
| 1040 | Part 2, JM-010 combination group A | - | - | - | - | 1件: 6 6 💬
|
| 1041 | Part 2, JM-010 combination group B | - | - | - | - | 1件: 6 6 💬
|
| 1042 | Part 2, JM-010 component group C | - | - | - | - | 1件: 6 6 💬
|
| 1043 | PEG-liposomal prednisolone sodium phosphate (Delta-cortef) | 2件: Phosphate ion Phosphate ion, Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 💬
|
| 1044 | Pentasa compact 2G, granulate with prolonged release | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1045 | Pentasa compact 4G, granulate with prolonged release | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1046 | Peptid coupled RED blood cells | - | - | - | - | 1件: 13 13 💬
|
| 1047 | Peptide coupled RED blood cells | - | - | - | - | 1件: 13 13 💬
|
| 1048 | Peptide-conjugated phosphorodiamidate morpholino oligomer FOR exon 51 skipping | - | - | - | - | 1件: 113 113 💬
|
| 1049 | Peptide-conjugated phosphorodiamide morpholino oligomer FOR exon 51 skipping | - | - | - | - | 1件: 113 113 💬
|
| 1050 | Perfluorinated GAS/oxygen mixture (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 299 299 💬
|
| 1051 | PF2020-cell (UC-mscs) - allogeneic human umbilical cord mesenchymal stem cells | - | - | - | - | 1件: 96 96 💬
|
| 1052 | Pfizer comirnaty vaccine | - | - | - | - | 1件: 97 97 💬
|
| 1053 | PFP and SF6 human lung coil | - | - | - | - | 1件: 299 299 💬
|
| 1054 | PGT-1 gene lipid complex | - | - | - | - | 1件: 299 299 💬
|
| 1055 | Phase 1: conventiaonal dmard | - | - | - | - | 1件: 46 46 💬
|
| 1056 | Phase 2. continous/bilevel positive airway presure with additional oxygen support BY devilbiss 525 KS oxygen concentrator | - | - | - | - | 1件: 230 230 💬
|
| 1057 | Piperacillin-tazobactam combination product | 1件: Piperacillin Piperacillin | 3件: Piperacillin sodium
Piperacillin sodium
,
Piperacillin
,
Piperacillin
💬
| - | - | 1件: 299 299 💬
|
| 1058 | Pittsburgh compound B | 1件: Pittsburgh Compound B Pittsburgh Compound B (Pittsburgh Compound B) | - | - | - | 1件: 127 127 💬
|
| 1059 | Pittsburgh compound B [11C]-PIB | 1件: Pittsburgh Compound B Pittsburgh Compound B (Pittsburgh Compound B) | - | - | - | 1件: 6 6 💬
|
| 1060 | Placental mesenchymal stem cells seeded ON A commercially available dural graft extracellular matrix | 1件: Placental Mesenchymal Stem Cells Placental Mesenchymal Stem Cells | - | - | - | 1件: 118 118 💬
|
| 1061 | Plaquenil - hydroxychloroquine 200MG film coated tablets | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 3件: 43 43, 44, 45 💬
|
| 1062 | Plasma-derived fviii/VWF concentrate | - | - | - | - | 1件: 288 288 💬
|
| 1063 | Plasticity-based computerized cognitive remediation program | - | - | - | - | 1件: 13 13 💬
|
| 1064 | Pneumococcal conjugate vaccine | - | - | - | - | 1件: 46 46 💬
|
| 1065 | Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated TO CRM197 carrier protein and adsorbed ON aluminium phosphate | - | - | - | - | 1件: 46 46 💬
|
| 1066 | Pneumovax - 10 siringhe preriempite CON AGO DA 0.5 ML | - | - | - | - | 1件: 62 62 💬
|
| 1067 | Polisaccaride dell'haemophilus influenzae DI tipo B coniugato CON LA proteina tetanica | - | - | - | - | 1件: 62 62 💬
|
| 1068 | Potable water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 19 19 💬
|
| 1069 | Potassium chloride (Klor-con, KLOR-CON, KLOR-CON M) | 2件: Potassium Potassium, Potassium chloride | 2件: Potassium chloride
Potassium chloride
(Klor-con, KLOR-CON, KLOR-CON M),
Potassium
💬
| - | - | 1件: 97 97 💬
|
| 1070 | Prednisolone (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
| 1071 | Prednisolone & dipyridamole (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1072 | Prednisolone + mabthera (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 💬
|
| 1073 | Prednisolone - prednisolone tablet (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 1074 | Prednisolone 1MG tablets (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 1075 | Prednisolone 2,5 MG tablets (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 1076 | Prednisolone 20 MG (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1077 | Prednisolone 40 MG (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1078 | Prednisolone 5 MG (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 51 💬
|
| 1079 | Prednisolone 5 MG tablets (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 1080 | Prednisolone 5MG gastro-resistant tablets (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬
|
| 1081 | Prednisolone 5MG tablet (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 1082 | Prednisolone acetate (Delta-cortef) | 2件: Prednisolone Prednisolone, Prednisolone acetate | 2件: Prednisolone
Prednisolone
(Delta-cortef),
Prednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬
|
| 1083 | Prednisolone and chlorambucil (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬
|
| 1084 | Prednisolone and mycophenolate mofetil (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬
|
| 1085 | Prednisolone and taper (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬
|
| 1086 | Prednisolone labesfal (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1087 | Prednisolone plus cyclophosphamide (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1088 | Prednisolone sodium metasulphobenzoate (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 1089 | Prednisolone sodium phosphate (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 3 3 💬
|
| 1090 | Prednisolone sodium phosphate oral solution (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 3 3 💬
|
| 1091 | Prednisolone sodium succinate (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 95 95 💬
|
| 1092 | Prednisolone tablets B.P. 5MG (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 1093 | Prednisolone tablets BP (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1094 | Prednisolone tablets BP 1 MG (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1095 | Prednisolone tablets USP 5 MG (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1096 | Prednisolone-dipyridamole (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1097 | Prednisolone/prednisone (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 💬
|
| 1098 | Prednisone DOC generici - 5 MG compresse 10 compresse IN blister PVC-pvdc/ALU | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 19 19 💬
|
| 1099 | Prednisone DOC generici - 5 MG compresse 30 compresse IN blister PVC-pvdc/ALU | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬
|
| 1100 | Prednisone or prednisolone (Delta-cortef) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 66 66, 84 💬
|
| 1101 | Probiotic capsules containing lactobacillus rhamnosus GR-1 and L. reuteri RC-14 | - | - | - | - | 1件: 46 46 💬
|
| 1102 | Probiotics combined with enteric-coated budesonide capsule | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1103 | Procaptan - 10 MG compresse rivestite CON film 60 compresse IN contenitore PER compresse PP | - | - | - | - | 1件: 58 58 💬
|
| 1104 | Procaptan - 5 MG compresse rivestite CON film 10 compresse IN contenitore PER compresse PP | - | - | - | - | 1件: 58 58 💬
|
| 1105 | Products containing aminosalicylate | - | - | - | - | 1件: 97 97 💬
|
| 1106 | Products containing azathioprine or 6-mercaptopurine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
| 1107 | Prophylactic corticosteroid taper regimen | - | - | - | - | 1件: 251 251 💬
|
| 1108 | Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor | - | - | - | - | 1件: 296 296 💬
|
| 1109 | Protein and calorie controlled diet | - | - | - | - | 1件: 251 251 💬
|
| 1110 | Prothrombin complex concentrate | 2件: Factor IX Complex (Human) Factor IX Complex (Human) (Coagulation factor IX complex human), Prothrombin (Coagulation factor II) | 1件: Factor IX complex
Factor IX complex
(Factor IX complex) 💬
| - | - | 1件: 288 288 💬
|
| 1111 | Provigil - 100 MG compresse 30 compresse | - | - | - | - | 1件: 113 113 💬
|
| 1112 | PRP combined magnovision | - | - | - | - | 1件: 90 90 💬
|
| 1113 | Pseudoephedrine + 480 ML water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 2件: Pseudoephedrine Pseudoephedrine, Water | 4件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers),
Pseudoephedrine hydrochloride
,
Pseudoephedrine sulfate
,
Pseudoephedrine
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 💬
|
| 1114 | Pseudoephedrine + 50 ML water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 2件: Pseudoephedrine Pseudoephedrine, Water | 4件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers),
Pseudoephedrine hydrochloride
,
Pseudoephedrine sulfate
,
Pseudoephedrine
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 💬
|
| 1115 | PTC0161480, PTC124 compound 1A, RPS2505, PTC-C124, 291844 | - | - | - | - | 1件: 113 113 💬
|
| 1116 | Purinethol - 50 MG compresse25 compresse | - | - | - | - | 1件: 96 96 💬
|
| 1117 | Pyridoxine plus prednisolone (Delta-cortef) | 2件: Prednisolone Prednisolone, Pyridoxine | 3件: Prednisolone
Prednisolone
(Delta-cortef),
Pyridoxine hydrochloride
,
Pyridoxine
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 145 145 💬
|
| 1118 | RAAV1.tmck.human-alpha-sarcoglycan- first cohort | - | - | - | - | 1件: 113 113 💬
|
| 1119 | RAAV1.tmck.human-alpha-sarcoglycan- second cohort | - | - | - | - | 1件: 113 113 💬
|
| 1120 | Radiprodil + CO-administered drugs | 1件: Radiprodil Radiprodil | - | - | - | 2件: 137 137, 158 💬
|
| 1121 | Rapamune - 1 MG 100 compresse rivestite IN blister USO orale | - | - | - | - | 1件: 2 2 💬
|
| 1122 | Rapamune 0.5 MG coated tablets | - | - | - | - | 1件: 280 280 💬
|
| 1123 | Rapamycin-calcitriol combination | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 158 158 💬
|
| 1124 | Raxone - 150 MG- compresse rivestite CON FILM- USO orale- flacone (hdpe)- 180 compresse | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 1件: 113 113 💬
|
| 1125 | Reaction time and postural control | - | - | - | - | 1件: 299 299 💬
|
| 1126 | Reactive corticosteroid taper regimen | - | - | - | - | 1件: 251 251 💬
|
| 1127 | Recombinant AAV vector serotype 2 containing THE human wild type mitochondrial ND4 gene | - | - | - | - | 1件: 302 302 💬
|
| 1128 | Recombinant AAV vector serotype 2 containing THE human wild typemitochondrial ND4 gene | - | - | - | - | 1件: 302 302 💬
|
| 1129 | Recombinant adeno-associated viral vector serotype 2.7m8 containing THE chrimsonr-tdtomato gene | - | - | - | - | 1件: 90 90 💬
|
| 1130 | Recombinant adenovirus containing THE ornithine transcarbamylase gene | - | - | - | - | 1件: 251 251 💬
|
| 1131 | Recombinant coagulation fviii FC – VON willebrand factor – xten fusion protein | 1件: Von Willebrand factor human Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 1132 | Recombinant coagulation fviii FC –VON willebrand factor – xten fusion protein | 1件: Von Willebrand factor human Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 1133 | Recombinant granulocyte - colony stimulating factor | - | - | - | - | 1件: 39 39 💬
|
| 1134 | Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-MAN6 glycan | - | - | - | - | 1件: 256 256 💬
|
| 1135 | Recombinant human ALFA-glucosidase conjugated with synthetic bismannose-6-phosphate-MAN6 glycan | - | - | - | - | 1件: 256 256 💬
|
| 1136 | Recombinant human angiotensin-converting enzyme 2 (ACE2), APN01 | 1件: Alunacedase alfa Alunacedase alfa (Recombinant Human Angiotensin-Converting Enzyme 2) | - | - | - | 1件: 86 86 💬
|
| 1137 | Recombinant human apolipoprotein A-I/phospholipids complex | - | - | - | - | 1件: 79 79 💬
|
| 1138 | Recombinant human coagulation factor viii FC - VON willebrand facto | 1件: Antihemophilic factor human Antihemophilic factor human (Human coagulation factor VIII) | - | - | - | 1件: 288 288 💬
|
| 1139 | Recombinant human coagulation factor viii FC - VON willebrand factor - xten fusion protein | - | - | - | - | 1件: 288 288 💬
|
| 1140 | Recombinant human coagulation factor viii FC - VON willebrand factor -xten fusion protein | 2件: Antihemophilic factor human Antihemophilic factor human (Human coagulation factor VIII), Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 1141 | Recombinant neisseria meningitidis group B fhbp fusion protein produced IN E.coli cells BY recombinant DNA technology adsorbed ON aluminium hydroxide | - | - | - | - | 1件: 11 11 💬
|
| 1142 | Recombinant SELF-complementary adeno-associated viral vector serotype 9 containing THE human CLN6 gene | - | - | - | - | 1件: 19 19 💬
|
| 1143 | Reduced dose OF cyclophosphamide combined with standard immunosuppressive therapy | - | - | - | - | 1件: 60 60 💬
|
| 1144 | Reduced intensity conditioning | - | - | - | - | 2件: 19 19, 65 💬
|
| 1145 | Reduced-dose conditioning regimen containing TBI IN hematopoietic stem cell transplantation treating elderly patients with aplastic anemia | - | - | - | - | 1件: 60 60 💬
|
| 1146 | Remicade - 100 MG polvere PER concentrato PER infusione endovenosa 1 flacone vetro 20 ML USO EV | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 1147 | Remicade 100 MG polvo para concentrado para solucióN para perfusióN | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 271 💬
|
| 1148 | Repository corticotropin injection | 1件: Corticotropin Corticotropin (Corticotrophin) | 2件: Corticotropin
Corticotropin
(Corticotropin, PURIFIED CORTROPHIN GEL),
Corticotropin, repository
(Corticotropin, repository, Cortigel) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 2 2, 13, 46, 84, 222 💬
|
| 1149 | Repository corticotropin injection -treatment extension | - | - | - | - | 1件: 84 84 💬
|
| 1150 | Respiratory and exercise therapy with supplemental oxygen (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 88 88 💬
|
| 1151 | Retrovirus construct | - | - | - | - | 1件: 285 285 💬
|
| 1152 | Revascularization/conservative management | - | - | - | - | 1件: 22 22 💬
|
| 1153 | Revatio 20 MG film coated tablets | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1154 | Revatio 20 MG FILM-coated tablets | - | - | - | - | 1件: 86 86 💬
|
| 1155 | Revatio 20 MG, comprimidos recubiertos CON PELícula | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1156 | Revolade - 25 MG - compressa rivestita CON film - USO orale - blister(PA/ALU/PVC/ALU) 28 compresse | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 1157 | Revolade - 50 MG - compressa rivestita CON film - USO orale - blister(PA/ALU/PVC/ALU | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 1158 | Revolade 25 MG FILM-coated tablets | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
| 1159 | Revolade 50 MG FILM-coated tablets | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
| 1160 | Rhtpo combined with herombopag + CSA | 1件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin | - | - | - | 1件: 60 60 💬
|
| 1161 | Rhtpo IN combination with rituximab | 1件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin | - | - | - | 1件: 63 63 💬
|
| 1162 | Ribavirin (Copegus) | 1件: Ribavirin Ribavirin | 1件: Ribavirin
Ribavirin
(Copegus) 💬
| - | - | 2件: 2 2, 96 💬
|
| 1163 | Rifaximin delayed release 400 MG film coated tablet | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 1164 | Rilutek 50 MG FILM-coated tablets | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
| 1165 | Rilutek 50 MG, FILM-coated tablets | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
| 1166 | Riluzolo teva - 50 MG compresse rivestite CON film 90 compresse IN blister AL/PVC | - | - | - | - | 1件: 114 114 💬
|
| 1167 | Riociguat coated tablet 0.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1168 | Riociguat coated tablet 1.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1169 | Riociguat coated tablet 1.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1170 | Riociguat coated tablet 2.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1171 | Riociguat coated tablet 2.5 M | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1172 | Riociguat coated tablet 2.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1173 | Riociguat film coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1174 | Risperidone (RISPERDAL CONSTA) | 1件: Risperidone Risperidone | 1件: Risperidone
Risperidone
(RISPERDAL CONSTA) 💬
| 2件: DRD2 DRD2, HTR2 💬
| 13件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 3件: 8 8, 156, 187 💬
|
| 1175 | Risperidone 1MG TAB (RISPERDAL CONSTA) | 1件: Risperidone Risperidone | 1件: Risperidone
Risperidone
(RISPERDAL CONSTA) 💬
| 2件: DRD2 DRD2, HTR2 💬
| 13件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
| 1176 | Rituximab combined with corticosteroids | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 1177 | Rituximab combined with omalizumab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 162 162 💬
|
| 1178 | Rituximab combined with tacrolimus induction + rituximab maintenance | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 1179 | Rituximab combined with tacrolimus induction + tacrolimus maintenance | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 1180 | Rituximab, cyclophosphamide, and corticosteroids | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 1181 | Rituximab-EU+ rituximab-pfizer X 2 courses | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1182 | Rituximab-pfizer (PF-05280586) X 3 courses | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1183 | Rituximab-US + rituximab-pfizer X 2 courses | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1184 | Roactemra - 20 MG/ML concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 4ML 1 flaconcino | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
| 1185 | Roactemra 20 MG/ML concentrado para solucióN para perfusióN | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
| 1186 | Roactemra 20 MG/ML concentrate FOR solution FOR infusion | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
| 1187 | Roactemra 20 MG/ML, concentrado para solucióN para perfusióN | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 46 46, 107, 271 💬
|
| 1188 | Ropinirole controlled-release (requip CR) FOR RLS | 1件: Ropinirole Ropinirole | 2件: Ropinirole hydrochloride
Ropinirole hydrochloride
,
Ropinirole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1189 | Ropivacaine, epinephrine, clonidine, and ketorolac injection cocktail | 1件: Ropivacaine Ropivacaine | 2件: Ropivacaine hydrochloride
Ropivacaine hydrochloride
,
Ropivacaine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 70 70 💬
|
| 1190 | S95011 concentrate FOR solution FOR infusion | - | - | - | - | 1件: 53 53 💬
|
| 1191 | SARS-COV-2 mrna vaccine | 2件: CVnCoV CVnCoV (SARS-CoV-2 mRNA vaccine), SARS-CoV-2 mRNA vaccine (SARS-CoV-2 mRNA vaccine) | - | - | - | 1件: 13 13 💬
|
| 1192 | Sativex - spray PER mucosa orale 3 flaconi nebulizzatori CON pompa dosatrice DA 10 ML - 90 erogazioni | - | - | - | - | 1件: 13 13 💬
|
| 1193 | Second-line cognitive assessment | - | - | - | - | 1件: 3 3 💬
|
| 1194 | Secukinumab (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 💬
|
| 1195 | Secukinumab 150 MG (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
| 1196 | Secukinumab 150 MG (2 injections PER dose (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 269 269 💬
|
| 1197 | Secukinumab 150 MG/1 ML solution FOR injection (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 2件: 37 37, 271 💬
|
| 1198 | Secukinumab 150 MG/ML (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬
|
| 1199 | Secukinumab 150MG (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 37 37 💬
|
| 1200 | Secukinumab 300 MG (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
| 1201 | Secukinumab 300MG (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 37 37 💬
|
| 1202 | Secukinumab 75 MG/0.5 ML solution FOR injection (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬
|
| 1203 | Secukinumab injection (Cosentyx, COSENTYX) | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
(Cosentyx, COSENTYX) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 160 160 💬
|
| 1204 | Selexipag film coated tablets | 1件: Selexipag Selexipag | 1件: Selexipag
Selexipag
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
| 1205 | Semi continuous intra-oral administration OF LD/CD | - | - | - | - | 1件: 6 6 💬
|
| 1206 | Sequential fecal microbiota transplant combined with small intestinal fluid transplant | - | - | - | - | 1件: 99 99 💬
|
| 1207 | Serum calcium concentrations results | - | - | - | - | 1件: 235 235 💬
|
| 1208 | Serum containing avonex | - | - | - | - | 1件: 13 13 💬
|
| 1209 | Serum metal ION levels determined TO monitor changes IN chromium and cobalt levels | - | - | - | - | 1件: 46 46 💬
|
| 1210 | Sham abdominal compression | - | - | - | - | 1件: 17 17 💬
|
| 1211 | Sham compression | - | - | - | - | 2件: 6 6, 17 💬
|
| 1212 | Sham control | - | - | - | - | 1件: 3 3 💬
|
| 1213 | Sham oxygen therapy (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 2件: 86 86, 88 💬
|
| 1214 | Short-course ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
| 1215 | Sildenafil and losartan (Cozaar, COZAAR) | 2件: Losartan Losartan, Sildenafil | 4件: Losartan potassium
Losartan potassium
(Cozaar, COZAAR),
Sildenafil citrate
,
Losartan
,
Sildenafil
💬
| 2件: AGTR1 AGTR1, PDE5 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1216 | Simultaneous combined 18F-FDG PET and cardiac MRI imaging | - | - | - | - | 1件: 84 84 💬
|
| 1217 | Simvastatin 40 MG FILM-coated tablets | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1218 | Simvastatina sandoz 40 MG comprimidos recubiertos CON PELícula EFG | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1219 | SIN LV mediated EX vivo transduced autologous fibroblasts expressing codon-optimised COL7a1 | - | - | - | - | 1件: 36 36 💬
|
| 1220 | SIN RV-mediated COL7a1 corrected autologous skin equivalent | - | - | - | - | 1件: 36 36 💬
|
| 1221 | Sinemet - 100 MG + 25 MG compresse 50 compresse divisibili | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1222 | Sinemet 100 MG + 25 MG compresse | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1223 | Single photon emission computed tomography | - | - | - | - | 1件: 34 34 💬
|
| 1224 | Single photon emission computed tomography scans | - | - | - | - | 1件: 98 98 💬
|
| 1225 | Sinvastatina sandoz 40 MG comprimidos revestidos POR PELícula | - | - | - | - | 1件: 13 13 💬
|
| 1226 | Site specific standard OF care comparison | - | - | - | - | 2件: 38 38, 39 💬
|
| 1227 | Sivatin 40 MG FILM-coated tablets | - | - | - | - | 1件: 13 13 💬
|
| 1228 | SOC corticosteroid - induction period | - | - | - | - | 1件: 96 96 💬
|
| 1229 | SOC corticosteroid - tapering | - | - | - | - | 1件: 96 96 💬
|
| 1230 | Sodio bicarbonato S.A.L.F. - 10 MEQ/10 ML concentrato PER soluzione PER infusione 5 fiale 10 ML | 1件: Sodium bicarbonate Sodium bicarbonate | 1件: Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | 1件: 299 299 💬
|
| 1231 | Soliris 300 MG concentrado para solucióN para perfusióN | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 109 109 💬
|
| 1232 | Soliris 300 MG concentrate FOR solution FOR infusion | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 1233 | SOLU-cortef | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 81, 83 💬
|
| 1234 | SOLU-cortef 100 MG injection | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬
|
| 1235 | Soluble prednisolone tablets (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 145 145 💬
|
| 1236 | Somatropin - adult cohort | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 193 193 💬
|
| 1237 | Somatropin - GH NAïVE pediatric cohort | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 193 193 💬
|
| 1238 | Somatropin - GH treated cohort | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 193 193 💬
|
| 1239 | Sorbitol (Sorbitol 3% in plastic container) | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
(Sorbitol 3% in plastic container) 💬
| - | - | 1件: 10 10 💬
|
| 1240 | Sorbitol sachet (Sorbitol 3% in plastic container) | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
(Sorbitol 3% in plastic container) 💬
| - | - | 1件: 97 97 💬
|
| 1241 | SP-101 and doxorubicin cohort 1 | 1件: SP-101 SP-101 | - | - | - | 1件: 299 299 💬
|
| 1242 | SP-101 and doxorubicin cohort 2 | 1件: SP-101 SP-101 | - | - | - | 1件: 299 299 💬
|
| 1243 | Sparsentan compresse | 1件: Sparsentan Sparsentan | 1件: Sparsentan
Sparsentan
💬
| 2件: AGTR1 AGTR1, EDNRA 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
| 1244 | Specimen collection | - | - | - | - | 2件: 215 215, 216 💬
|
| 1245 | Spironolactone and conivaptan | 1件: Spironolactone Spironolactone | 1件: Spironolactone
Spironolactone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 1件: 86 86 💬
|
| 1246 | Spironolactone mylan 25 MG comprimé pelliculé Sécable | 1件: Spironolactone Spironolactone | 1件: Spironolactone
Spironolactone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 1件: 46 46 💬
|
| 1247 | Sputum collection | - | - | - | - | 2件: 299 299, 340 💬
|
| 1248 | Standard blood pressure control | - | - | - | - | 1件: 67 67 💬
|
| 1249 | Standard continuous antiretroviral therapy | - | - | - | - | 1件: 265 265 💬
|
| 1250 | Standard gadolinium contrast | - | - | - | - | 1件: 13 13 💬
|
| 1251 | Standard IST combined with romiplostim N01 | - | - | - | - | 1件: 60 60 💬
|
| 1252 | Standard oxygen therapy/RA (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 299 299 💬
|
| 1253 | Standard treatment with A conventional drug | - | - | - | - | 1件: 13 13 💬
|
| 1254 | Stelara 130 MG concentrate FOR solution FOR infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 1255 | Stelara 130MG / 26ML concentrate FOR solution FOR infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 1256 | Stem cell collection | - | - | - | - | 1件: 28 28 💬
|
| 1257 | Stem cell or umbilical cord blood transplantation | - | - | - | - | 1件: 326 326 💬
|
| 1258 | Strength training IN shallow water and DRY land (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 6 6 💬
|
| 1259 | Subcutaneous hydrocortisone (Colocort, Cortef, CORTEF, CORTENEMA) | - | - | - | - | 1件: 81 81 💬
|
| 1260 | Subcutaneous hydrocortisone 10MG (Colocort, Cortef, CORTEF, CORTENEMA) | 1件: Hydrocortisone Hydrocortisone (Cortisol) | 1件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1261 | Subcutaneous polyvidone collagen | - | - | - | - | 1件: 46 46 💬
|
| 1262 | Sulphsalazine, pentasa, asacol, colazide, depentum | - | - | - | - | 1件: 97 97 💬
|
| 1263 | Supplemental oxygen therapy (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 2件: 86 86, 88 💬
|
| 1264 | Supplemental oxygen VIA A mask (COMPRESSED OXYGEN, MEDICAL OXYGEN COMPRESSED, OXYGEN COMPRESSED, OXYGEN, COMPRESSED U.S.P.) | - | - | - | - | 1件: 88 88 💬
|
| 1265 | Suspension containing 250 embryonated, viable trichuris suis OVA (TSO)/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1266 | Suspension containing 250 embryonated, viable TSO/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1267 | Suspension containing 2500 embryonated, viable trichuris suis OVA (TSO)/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1268 | Suspension containing 2500 embryonated, viable TSO/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1269 | Suspension containing 7500 embryonated viable trichuris suis OVA/15ML | - | - | - | - | 1件: 97 97 💬
|
| 1270 | Suspension containing 7500 embryonated, viable trichuris suis OVA (TSO)/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1271 | Symkevi 100MG/150MG FILM-coated tablets | 2件: Ivacaftor Ivacaftor, Tezacaftor | 2件: Ivacaftor
Ivacaftor
,
Tezacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1272 | Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mrna transcripts | - | - | - | - | 2件: 2 2, 127 💬
|
| 1273 | T-peptide-CRM197 conjugate | - | - | - | - | 1件: 11 11 💬
|
| 1274 | Tachipirina - 500 MG compresse10 compresse | - | - | - | - | 1件: 28 28 💬
|
| 1275 | Tachipirina - 500 MG compresse20 compresse | - | - | - | - | 1件: 13 13 💬
|
| 1276 | Tacrolimus combined with prednisone | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
| 1277 | Tadalafil 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1278 | Tadalafil and ambrisentan upfront combination therapy | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬
|
| 1279 | TAT4 GEL concentration A | - | - | - | - | 1件: 265 265 💬
|
| 1280 | TAT4 GEL concentration B | - | - | - | - | 1件: 265 265 💬
|
| 1281 | TEA consumption | - | - | - | - | 1件: 46 46 💬
|
| 1282 | Technetium [TC-99M] sulfur colloid and indium [IN-111] dtpa | - | - | - | - | 1件: 299 299 💬
|
| 1283 | Technetium sulfur colloid | - | - | - | - | 1件: 299 299 💬
|
| 1284 | Telephone-based cognitive behavioral therapy | - | - | - | - | 1件: 13 13 💬
|
| 1285 | Teriparatide conjugated TO A multiarm polyethylene glycol carrier molecule through A cleava | 1件: Teriparatide Teriparatide | 3件: Teriparatide acetate
Teriparatide acetate
,
Teriparatide
,
Teriparatide acetate
💬
| 1件: PTH1R PTH1R 💬
| 4件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬
|
| 1286 | Teriparatide conjugated TO A multiarm polyethylene glycol carrier molecule through A cleavable linker | 1件: Teriparatide Teriparatide | 3件: Teriparatide acetate
Teriparatide acetate
,
Teriparatide
,
Teriparatide acetate
💬
| 1件: PTH1R PTH1R 💬
| 4件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬
|
| 1287 | Tetracosactide acetate (Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN) | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 83 83, 145 💬
|
| 1288 | Tetracosactide esacetato (Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN) | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
| 1289 | Tetracosactide hexaacetate (Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN) | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
| 1290 | Tetracosactide hexacetaat (Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN) | 1件: Tetracosactide Tetracosactide (beta-corticotrophin) | 2件: Cosyntropin
Cosyntropin
(Cosyntropin, Cortrosyn, CORTROSYN, COSYNTROPIN),
Tetracosactide acetate
(Cortrosyn) 💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 222 222 💬
|
| 1291 | TGF-beta recettore DI tipo II extracellulare, collegata A UN dominio FC umano modificato dell’immuno | - | - | - | - | 1件: 51 51 💬
|
| 1292 | THE 0.5 ML dose OF vaccine contains 25 micrograms OF each OF THE following 23 pneumococcal polysaccharide | - | - | - | - | 1件: 222 222 💬
|
| 1293 | THE comprehensive treatment regimen OF traditional chinese medicine | - | - | - | - | 1件: 222 222 💬
|
| 1294 | THE conventional balance exercise program | - | - | - | - | 1件: 6 6 💬
|
| 1295 | THE generic name IS warfarin and many producers will BE involved (Coumadin) | 1件: Warfarin Warfarin (Coumafene) | 3件: Warfarin sodium
Warfarin sodium
(Coumadin),
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 49 49 💬
|
| 1296 | THE patients' parents have TO complete THE vineland II adaptive behavior scales scoring, THE sleep disturbance scale FOR children (sdsc) and horne & ostberg circadian typology questionnaire | - | - | - | - | 1件: 149 149 💬
|
| 1297 | THE YI-QI-QING-JIE herbal compound | - | - | - | - | 1件: 66 66 💬
|
| 1298 | Thymoglobuline - 5 MG/ML polvere PER concentrato PER soluzione PER infusione 1 fiala DA 10 ML | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 1件: 51 51 💬
|
| 1299 | Timolol alcon 0.5% collyre | 1件: Timolol Timolol | 3件: Timolol
Timolol
,
Timolol maleate
,
Timolol
💬
| 2件: ADRB1 ADRB1, ADRB2 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 227 227 💬
|
| 1300 | Tissue selective estrogen complex | - | - | - | - | 1件: 13 13 💬
|
| 1301 | TO BE confirmed | - | - | - | - | 3件: 46 46, 65, 97 💬
|
| 1302 | Tobi 300MG/ 5ML solucióN para inhalacióN CON nebulizador | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 1303 | Tocilizumab and IV steroids combination | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 41 41 💬
|
| 1304 | Topical compound tripterygium | - | - | - | - | 1件: 46 46 💬
|
| 1305 | Tozinameran (COVID-19 mRNA vaccine, Comirnaty, Pfizer-biontech Covid-19 vaccine, COMIRNATY) | 1件: Tozinameran Tozinameran (Pfizer-BioNTech COVID-19 Vaccine) | 1件: Tozinameran
Tozinameran
(COVID-19 mRNA vaccine, Comirnaty, Pfizer-biontech Covid-19 vaccine, COMIRNATY) 💬
| - | - | 1件: 299 299 💬
|
| 1306 | TP05 coating A | - | - | - | - | 1件: 97 97 💬
|
| 1307 | TP05 coating B | - | - | - | - | 1件: 97 97 💬
|
| 1308 | TP05 coating D | - | - | - | - | 1件: 97 97 💬
|
| 1309 | TP05 coating E | - | - | - | - | 1件: 97 97 💬
|
| 1310 | TP05 coating H | - | - | - | - | 1件: 97 97 💬
|
| 1311 | TPO-RAS combining ANTI-CD 20 monoclonal antibody | - | - | - | - | 1件: 63 63 💬
|
| 1312 | Tralokinumab cohort 1 | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 💬
|
| 1313 | Tralokinumab cohort 2 | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 💬
|
| 1314 | Tramadol (CONZIP) | 1件: Tramadol Tramadol | 2件: Tramadol hydrochloride
Tramadol hydrochloride
(CONZIP),
Tramadol
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 70, 226 💬
|
| 1315 | Tramadol /acetaminophen (CONZIP) | 1件: Tramadol Tramadol | 2件: Tramadol hydrochloride
Tramadol hydrochloride
(CONZIP),
Tramadol
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 271 271 💬
|
| 1316 | Tramadol hydrochloride + acetaminophen (CONZIP) | 1件: Tramadol Tramadol | 2件: Tramadol hydrochloride
Tramadol hydrochloride
(CONZIP),
Tramadol
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1317 | Tramadol with ropivacaine (CONZIP) | 2件: Ropivacaine Ropivacaine, Tramadol | 4件: Tramadol hydrochloride
Tramadol hydrochloride
(CONZIP),
Ropivacaine hydrochloride
,
Ropivacaine
,
Tramadol
💬
| 6件: OPRM1 OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 8件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬 | 1件: 70 70 💬
|
| 1318 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with A COL17a1-encoding retroviral vector | - | - | - | - | 1件: 36 36 💬
|
| 1319 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with A COL7a1-encoding retroviral vector | - | - | - | - | 1件: 36 36 💬
|
| 1320 | Treatment VS control bread | - | - | - | - | 1件: 97 97 💬
|
| 1321 | Treatment with topical superpotent corticosteroid therapy | - | - | - | - | 1件: 162 162 💬
|
| 1322 | Trexan+salazopyrin+oxiklorin+prednisolone + infliximab (Delta-cortef) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1323 | Triple combination therapy | - | - | - | - | 1件: 299 299 💬
|
| 1324 | Triple-combination therapy | - | - | - | - | 1件: 86 86 💬
|
| 1325 | Triptolide-containing formulation | 1件: Triptolide Triptolide | - | - | - | 1件: 67 67 💬
|
| 1326 | Triterpene DRY extract from birch cork | - | - | - | - | 1件: 36 36 💬
|
| 1327 | Twice daily 90 MG hydrocortisone acetate suppository administered with sephure applicator (Colocort, Cortef, CORTEF, CORTENEMA) | 3件: Acetate Acetate, Hydrocortisone (Cortisol), Hydrocortisone acetate (Cortisol 21-acetate) | 2件: Hydrocortisone
Hydrocortisone
(Colocort, Cortef, CORTEF, CORTENEMA),
Hydrocortisone acetate
(Cortifoam, U-cort, CORTIFOAM) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 1328 | Tysabri 300 MG concentrado para solucióN para perfusióN | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1329 | Tysabri 300 MG concentrate FOR solution FOR infusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1330 | Ulcerative colitis diet | - | - | - | - | 1件: 97 97 💬
|
| 1331 | Ulcerative colitis exclusion diet | - | - | - | - | 1件: 97 97 💬
|
| 1332 | Ultomiris - 300 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 3 ML (100 MG / ML) - 1 flaconcino | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 1333 | Ultrasonographic assessment OF cervical multifidus and longus colli muscle thickness, postural balance and limit OF stability using THE balance platform,cervical flexion and extension strength | - | - | - | - | 1件: 271 271 💬
|
| 1334 | Ultrasound microbubble contrast agent | - | - | - | - | 1件: 96 96 💬
|
| 1335 | Umbilical cord blood | - | - | - | - | 1件: 60 60 💬
|
| 1336 | Umbilical cord blood after myeloablative conditioning | - | - | - | - | 1件: 60 60 💬
|
| 1337 | Umbilical cord blood after reduced-intensity conditioning | - | - | - | - | 1件: 60 60 💬
|
| 1338 | Umbilical cord blood CD19-bcma CAR-T cells infusion | - | - | - | - | 2件: 51 51, 53 💬
|
| 1339 | Umbilical cord blood mononuclear cells | - | - | - | - | 1件: 97 97 💬
|
| 1340 | Umbilical cord blood therapy | - | - | - | - | 2件: 2 2, 6 💬
|
| 1341 | Umbilical cord blood transplantation | - | - | - | - | 5件: 60 60, 65, 284, 285, 326 💬
|
| 1342 | Umbilical cord blood unit | - | - | - | - | 1件: 333 333 💬
|
| 1343 | Umbilical cord derived mesenchymal stem cell (UC -MSC) transplantation | - | - | - | - | 2件: 93 93, 296 💬
|
| 1344 | Umbilical cord derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 1345 | Umbilical cord lining stem cells | - | - | - | - | 1件: 50 50 💬
|
| 1346 | Umbilical cord mesenchymal stem cell | - | - | - | - | 1件: 113 113 💬
|
| 1347 | Umbilical cord mesenchymal stem cells | - | - | - | - | 5件: 13 13, 46, 57, 97, 113 💬
|
| 1348 | Unrelated umbilical cord blood transplant | - | - | - | - | 1件: 19 19 💬
|
| 1349 | Untreated cohort | - | - | - | - | 1件: 85 85 💬
|
| 1350 | Untreated contemporaneous cohort | - | - | - | - | 1件: 118 118 💬
|
| 1351 | Upadacitinib - direct compression-yellow | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
| 1352 | Upadacitinib -direct compression-yellow | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
| 1353 | Uptravi® film coated tablets | 1件: Selexipag Selexipag | 1件: Selexipag
Selexipag
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
| 1354 | Urbason 40 MG comprimidos | - | - | - | - | 1件: 13 13 💬
|
| 1355 | Urinary collect | - | - | - | - | 1件: 299 299 💬
|
| 1356 | Urine collection | - | - | - | - | 3件: 19 19, 215, 216 💬
|
| 1357 | Urine samples collect | - | - | - | - | 1件: 234 234 💬
|
| 1358 | Ursodeoxycholic acid combination OF immunosuppressive agents | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 2件: 93 93, 95 💬
|
| 1359 | Ursodeoxycholic acid combined with total glucosides OF paeony | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 1360 | Ursofalk® 500 MG FILM-coated tablets | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 1361 | Usual DMT continuation | - | - | - | - | 1件: 13 13 💬
|
| 1362 | V1512 and entacapone (Comtan, COMTAN) | - | - | - | - | 1件: 6 6 💬
|
| 1363 | Vaccino contro IL memingococco DI gruppo B | - | - | - | - | 3件: 61 61, 62, 66 💬
|
| 1364 | Vaccino haemophilus influenzae B coniugato CON proteina difterica CRM197 | - | - | - | - | 1件: 62 62 💬
|
| 1365 | Vaccino haemophilus influenzae B coniugato CON tossoidetetanico | - | - | - | - | 3件: 61 61, 62, 66 💬
|
| 1366 | Valproid acid plus corticosteroids | - | - | - | - | 1件: 26 26 💬
|
| 1367 | Vastarel 20MG film coated tablets | - | - | - | - | 1件: 58 58 💬
|
| 1368 | Vaxzevria suspension FOR injection covid-19 vaccine (chadox1-S | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine (Coronavirus Disease vaccine ChAdOx1 nCoV-19) | - | - | - | 1件: 299 299 💬
|
| 1369 | Vector viral adenoasociado DE serotipo 9 QUE contiene EL GEN DE LA sulfamidasa humana | - | - | - | - | 1件: 19 19 💬
|
| 1370 | Vehice control | - | - | - | - | 1件: 96 96 💬
|
| 1371 | Vehicle control | - | - | - | - | 2件: 36 36, 53 💬
|
| 1372 | Verapamil (Covera-hs) | 1件: Verapamil Verapamil | 2件: Verapamil hydrochloride
Verapamil hydrochloride
(Covera-hs),
Verapamil
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 58 58, 96, 140, 167 💬
|
| 1373 | Verapamil hydrochloride (Covera-hs) | 1件: Verapamil Verapamil | 2件: Verapamil hydrochloride
Verapamil hydrochloride
(Covera-hs),
Verapamil
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 1374 | Verapamil SR (Covera-hs) | 1件: Verapamil Verapamil | 2件: Verapamil hydrochloride
Verapamil hydrochloride
(Covera-hs),
Verapamil
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
| 1375 | Verapamil tablet (Covera-hs) | 1件: Verapamil Verapamil | 2件: Verapamil hydrochloride
Verapamil hydrochloride
(Covera-hs),
Verapamil
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 1376 | Vett lentiviral CON gene ABCA4 | - | - | - | - | 1件: 301 301 💬
|
| 1377 | Viokase 16 (pancrelipase) + nexium (Cotazym) | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 298 298 💬
|
| 1378 | Viread - 245 MG 30 compresse rivestite CON film IN flacone USO orale | - | - | - | - | 1件: 46 46 💬
|
| 1379 | Volibris 10 MG comprimidos recubiertos CON PELícula | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1380 | Volibris 5 MG comprimidos recubiertos CON PELícula | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1381 | Voluntary cough test | - | - | - | - | 1件: 6 6 💬
|
| 1382 | Voluntary peak cough flow testing | - | - | - | - | 1件: 2 2 💬
|
| 1383 | VON willebrand factor and coagulation factor viii IN combination | 1件: Von Willebrand factor human Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 1384 | VON willebrand factor concentrates and factor viii concentrates | 1件: Von Willebrand factor human Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 1385 | VON willebrand factor ristocetin cofactor | 1件: Von Willebrand factor human Von Willebrand factor human (Von willebrand factor complex) | - | - | - | 1件: 288 288 💬
|
| 1386 | VWD factor viii concentrate | - | - | - | - | 1件: 288 288 💬
|
| 1387 | VWF-containing products | - | - | - | - | 1件: 288 288 💬
|
| 1388 | VX-661 plus ivacaftor combination | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1389 | Warfarin (Coumadin) | 1件: Warfarin Warfarin (Coumafene) | 3件: Warfarin sodium
Warfarin sodium
(Coumadin),
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 10件: 6 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬
|
| 1390 | Warfarin 10 MG (Coumadin) | 1件: Warfarin Warfarin (Coumafene) | 3件: Warfarin sodium
Warfarin sodium
(Coumadin),
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 2件: 96 96, 97 💬
|
| 1391 | Warfarin potassium (Coumadin) | 1件: Warfarin Warfarin (Coumafene) | 3件: Warfarin sodium
Warfarin sodium
(Coumadin),
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 88 88 💬
|
| 1392 | Warfarin sodium (Coumadin) | 1件: Warfarin Warfarin (Coumafene) | 3件: Warfarin sodium
Warfarin sodium
(Coumadin),
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 49 49 💬
|
| 1393 | Warfarin sodium tablets (Coumadin) | 1件: Warfarin Warfarin (Coumafene) | 3件: Warfarin sodium
Warfarin sodium
(Coumadin),
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 46 46 💬
|
| 1394 | Warfarin+ vitamin K (Coumadin) | 1件: Warfarin Warfarin (Coumafene) | 3件: Warfarin sodium
Warfarin sodium
(Coumadin),
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 46 46 💬
|
| 1395 | Warm compress prior TO injection OF glatiramer acetate | 1件: Glatiramer Glatiramer (Copolymer I) | 1件: Glatiramer acetate
Glatiramer acetate
(Copaxone, COPAXONE) 💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 1396 | Warm salt water bath (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | - | - | - | - | 1件: 46 46 💬
|
| 1397 | Water (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 25件: 2 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
|
| 1398 | Water exercises (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 46 46 💬
|
| 1399 | Water FOR injection (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 35 35 💬
|
| 1400 | Water FOR injections, EP (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 299 299 💬
|
| 1401 | Water immersion (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 97 97 💬
|
| 1402 | Water or milk (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 97 97 💬
|
| 1403 | Water preparation (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 96 96 💬
|
| 1404 | Water prescription (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 67 67 💬
|
| 1405 | Water reduction AT home (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 2件: 72 72, 225 💬
|
| 1406 | Water tracking (Purified water in containers, Sterile purified water in containers, Water for injection in containers) | 1件: Water Water | 1件: Water
Water
(Purified water in containers, Sterile purified water in containers, Water for injection in containers) 💬
| - | - | 1件: 13 13 💬
|
| 1407 | Xadago - 100 MG- compressa rivestita CON FILM- USO orale- blister (PVC/pvdc/alluminio)- 30 compresse | 1件: Safinamide Safinamide | 2件: Safinamide
Safinamide
,
Safinamide mesylate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1408 | Xadago - 50 MG- compressa rivestita CON FILM- USO orale- blister (PVC/pvdc/alluminio)- 30 compresse | 1件: Safinamide Safinamide | 2件: Safinamide
Safinamide
,
Safinamide mesylate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1409 | Xeljanz 5 MG FILM-coated tablets | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬
|
| 1410 | Xeljanz 5MG FILM-coated tablets | - | - | - | - | 1件: 97 97 💬
|
| 1411 | Xenon contrast agent | 1件: Xenon Xenon | 2件: Xenon
Xenon
,
Xenon Xe 133
💬
| - | - | 1件: 22 22 💬
|
| 1412 | Yondelis 0,25 MG polvo para concentrado para solucióN para perfusióN | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬
| - | - | 1件: 159 159 💬
|
| 1413 | Yondelis 1 MG polvo para concentrado para solucióN para perfusióN | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬
| - | - | 1件: 159 159 💬
|
| 1414 | Zeposia® indicated FOR THE treatment OF: relapsing forms OF multiple sclerosis, and active ulcerative colitis IN adults | - | - | - | - | 2件: 13 13, 97 💬
|
| 1415 | Zinc and copper | 1件: Zinc Zinc | - | - | - | 1件: 2 2 💬
|
| 1416 | Zuglimet - 500 MG compresse rivestite CON film 30 compresse IN blister PVC/AL | - | - | - | - | 1件: 67 67 💬
|
| 1417 | Zytiga - 250 MG - compressa - USO orale - flacone 120 compresse | 1件: Abiraterone Abiraterone | 1件: Abiraterone acetate
Abiraterone acetate
💬
| 1件: CYP17A CYP17A 💬
| 5件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|